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Abstract 
Malignant cancers are a major cause of morbidity in the UK, accounting for a 
quarter of all deaths. Chemotherapy is considered to be the most effective 
treatment; however, cancer cells can become simultaneously resistant to 
different chemotherapeutic drugs that have no common structure- a 
phenomenon called multidrug resistance (MDR). This is a serious impediment to 
the successful treatment of many human cancers and is responsible for many 
tens of thousands of deaths each year. Cells can acquire MDR via more than 
one route. The more widely studied MDR mechanism involves the 
overexpression of membrane proteins such as P-glycoprotein (P-gp), which is 
thought to eject the drug from within the membrane before it exerts its cytotoxic 
effects. The second mechanism is mediated by other ion transporters, and 
results in changes in the pH of various compartments of the cell which allows the 
cell to sequester and subsequently eject drugs before they act. 
This thesis presents a study of the biophysical properties of cancer cells in a 
range of pharmacological scenarios, focusing on the effects of pharmacological 
agents both on drug-sensitive and multidrug resistant leukaernic and breast 
cancer cell lines. In this work, dielectrophoresis has been used as a non-invasive 
technique to examine dielectric properties of drug resistant and sensitive cancer 
cells before and after treatment with anti cancer drugs, and with a 
chemosensitiser. These results provide a better understanding of the physiology 
of different types of cancer cells, and allowed direct comparisons of dielectric 
properties of the membrane and cytoplasm. Specifically, this work examines the 
biophysical changes in both P-gp and non-P-gp mediated MDR cell lines, and at 
different stages of apoptosis (programmed cell death). In all three, cellular 
processes are characterised by changes in the ionic state of the cells, as well as 
changes in the physiology of the membrane. 
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1. Introduction 
Malignant cancers are a major cause of morbidity in the UK, over 245,000 new 
cases were registered in 1995. They account for a quarter of all deaths. 1 in 3 
people are considered at risk in his/ her lifetime and over 65% of all new cases 
are diagnosed in people over 65 years of age (The Cancer Research Campaign, 
1998- 99). There are over 200 types of cancer, the most common of those are 
lung, breast, bowel and the leukaernias. The latter accounts for a third of all 
cases (The Cancer Research Campaign, 1998-99). The usual ways of treatment 
were reported to involve, local excision and/or radiation, chemotherapy for 
patients with haernatological malignancies, immunotherapy and biological- 
response modifiers (as reviewed in Goftesman et al, 2002). Cancers are 
classified according to the tissue and cell type from which they arise. Those 
arising from epithelial cells and connective tissue are termed carcinomas and 
sarcomas, respectively. Those that do not fit into any category are the 
leukaemias and arise from different haernopoietic cells (Alberts et al, 1994). 
Chemotherapy is considered to be the most effective treatment for metastatic 
turnours. However, cancer cells can become simultaneously resistant to different 
chemotherapeutic drugs that have no common structure- a phenomenon called 
multidrug resistance (MDR). This is a serious impediment to the successful 
treatment of many human cancers and is responsible for many tens of thousands 
of deaths each year, as reviewed by Gottesman et al (2002) and Rosenberg et al 
(1997). MDR causes an increase in drug efflux, and in turn, lowers the 
intracellular drug concentrations, as reviewed by Ford (1996). The resistance of 
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neoplastic cells to cytotoxic drugs may be intrinsic (present before the drug is 
first given) or 'acquired' (developed during drug treatment). The acquired 
resistance may either be due to adaptation of the tumour cells or to mutation 
(Rang et al, 1995). 
1.1. Mechanisms of Multi-Drug Resistance (MDR) 
Cells can acquire MDR via more than one route. The way some MDR cells 
operate can involve one or more mechanisms. The more widely studied MDR 
mechanism involves the overexpression of membrane proteins which are 
thought to eject the drug from within the membrane before it reaches the 
cytoplasm. These proteins form a family known as the ATP binding cassette 
(ABC or ABCC) proteins. The second method is mediated by other ion 
transporters, and results in changes in the pH of various compartments of the 
cell which allows the cell to sequester and subsequently eject drugs before they 
act. We will now consider these in more detail. 
1.1.1. ABC-related MDR 
Over 40 years ago, it was recognised that certain proteins were able to transport 
substances across cellular membranes and against a concentration gradient. It 
was early reallsed that these processes require the input of energy and the 
hydrolysis of ATP, directly or indirectly. A large subclass of these proteins has 
been described, known as the ABC proteins (ATP- binding cassette), named for 
their distinctive domains that bind ATP. These sequences, known as Walker A 
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and Walker B, reside in the nuclear binding domain (NBD) and are highly 
conserved across many species (Litman et al, 2001). 
Classic MDR generally results from the expression of ATP- dependent efflux 
pumps with drug specificity. Resistance results because increased drug efflux 
lowers the intracellular drug concentrations. An example of the group of drugs 
that is affected by MDR is the anthracyclines (that includes doxorubicin), as well 
as other natural product agents such as vincristine, paclitaxel (Taxol) and VP-16 
(Gottesman et al, 2002 and Ford, 1996). 
The MDR phenotype was first linked to the over- expression of a 170 kDa 
membrane glycoprotein, named as P- glycoprotein (P- gp, P for permeability). 
This protein was found by Juliano and Ling (1976), and was the first known 
human ABC protein capable of transporting drugs out of the cell. P- gp is the 
product of the (MDRI) gene, made from 12 transmembrane regions that bind 
hydrophobic, either neutral or positively charged, drug substrates. It has been 
demonstrated by immunohistochemistry that P- gp is highly expressed in colon, 
kidney, adrenocortical and hepatocellular cancers (Gottesman et al, 2002). 
In non-MDR cells, cytotoxic agents such as doxorubicin can permeate through 
the plasma membrane, exert their cytotoxic effects which leads to cell death. In 
MDR cells, the drugs are effluxed from the lipid phase and cannot accumulate in 
the cell. Reports reviewed (Higgins and Gottesman, 1992) and (Higgins and 
Linton, 2001) that P- gp acts as a 'flippase', whereby the drug interacts with the 
membrane lipids before it interacts with the actual protein, and drug that is 
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intercalated into the inner leaflet of the lipid bilayer is either pumped directly into 
the extracellular space or is flipped by the protein into the outer leaflet. P- gp 
function was reported to require two ATP hydrolysis events to transport one drug 
molecule. The binding of substrate to the transmembrane regions stimulates the 
ATPase activity causing a conformational change that releases the substrate to 
either the outer leaflet of the membrane or the extracellular space. Hydrolysis at 
the second ATP site seems to be needed to re- set the P- gp to bind the 
substrate again, thus completing one catalytic cycle (Gottesman et al, 2002). 
The flow diagram (Figure 1.1) summarises the possible roles of P- gp, beyond its 
protective functions, suggested in recent literature (Ferte, 2000): 
Figure 1.1: Summary of P- gp role 
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Paclitaxel (Taxol) is a commonly used anticancer agent, excreted from the 
intestine via P-gp. Gene- targeting studies have demonstrated that P- gp is 
responsible for fecal excretion of 85% of orally administered Taxol (Scuetz, and 
Strom, 2001). P- gp can be found in normal tissues, it is located in the luminal 
surface of endothelial cells of capillaries forming the blood- brain- barrier and 
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preventing the penetration of cytotoxins across the endothelium (Gottesman et 
al, 2002). 
As not all MDR cells express P- gp, a search for other efflux pumps was initiated 
leading to the discovery of multidrug- resistance- associated protein 1 (MRP1), 
which was identified and characterised by Cole et al (1992) and Grant et al 
(1994). This 190 kDa protein is another ABC transporter and is similar to P- gp in 
structure, with the exception of an amino terminal extension containing five 
membrane- spanning domains attached to a P- gp-like core. Human P- gp and 
MRP1 share 15% amino acid homology. MRP1 transports drugs such as 
vincristine and Taxol. MRP was discovered because of its over- expression in a 
number of MDR human cell lines that do not over- express P- gp. In addition, 
MRP1 has been shown to be expressed in several normal tissues including the 
liver (Jedlitschky et al, 1996). In addition MRP1 proteins have been shown to be 
localised to the basolateral membrane of choroids plexus, where they serve to 
pump the metabolic waste products of cerebrospinal fluid (CSF) into the blood 
(reviewed in Gottesman et al, 2002). Other ABC transporters associated with 
MDR and the breast cancer resistance protein (BCRP) and the lung resistance 
protein (LRP) (Maliepaard et al, 1999; lzquierdo et al, 1995). 
1.1.2. Non-ABC MDR Mechanisms 
Another mechanism has been suggested for the acquisition of MDR, which does 
not require the expression of ABC transporter overexpression. Instead, this 
mechanism is related to the sequestration of drugs within vesicles and 
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cytoplasmic organelles away from the target site (Sognier et al, 1994; Slapak et 
al, 1992; and reviewed in Dietel, 1991). 
These cells are reported to have an alkaline cytoplasmic pH (Warburg, 1956; 
Simon and Schindler, 1994), while the vesicular pH is more acidic in resistant 
than sensitive cells. Schindler et a[ (1996) explained that sensitive cells exhibited 
a diminished capacity to remove cytotoxic drugs from the cytoplasm by 
sequestration of protonated drugs within the vesicles. The group suggested that 
protonation of anti-cancer drugs causes them to be sequestered in vesicles, 
allowing them to be secreted later and thus preventing them reaching their 
target. 
1.1.2. MDR modulators 
Recent literature (Litman et al, 2001) reviewed how this transport could be 
blocked, and MDR reversed by the addition of substrate analogues, the so- 
called MDR modulators or chemosensitisers. Many have been developed, such 
as the PSC833 (one of the second generation modulators) and XR9576 (a third 
generation modulator that has reached phase III in clinical trials). However, their 
precise mechanism of their action remains unclear, although a good deal of 
research has been carried out thus far. 
A large number of drugs have been identified which inhibit the function of P- gp. 
Just as the anticancer substrates are diverse in chemical structure and function, 
so too are MDR "modulators". They fall into six broad categories: a) calcium 
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channel blockers, b) calmodulin antagonists, c) cyclic peptides, d) steroids and 
hormonal analogues, e) dipyrimadole, and ý miscellaneous other compounds 
(Ford, 1996). Most of these modulators (such as verapamil and cyclosporin A, 
known as "First generation MDR modulators") are themselves non- specific, 
weak inhibitors and substrates for the P- gp pump (Fisher et al, 1996). An 
exception to this is the cyclosporin analogue PSC833, one of the "Second 
generation modulators". Its intracellular accumulation is not altered by 
expression of P- gp and is less toxic (Krishna et al, 2000). A recent review 
(Litman et al, 2001) supported the notion that PSC833 is a substrate of P- gpl 
and when it competes with the anticancer drug (such as verapamil or 
daunorubicin), it will win out due to its higher affinity. However, since the 
transport rate is slower, it will slow down the turnover rate, which will decrease 
the ATPase activity. It might, therefore, be better to regard PSC83 as partial 
antagonist, as it does not completely block P- gp, but slows it down; PSC833 is a 
bulky molecule that will act as an obstructive substrate. Second generation P-gp 
modulators have a better pharmacologic profile than the first generation 
compounds, but they also retain some characteristics that limit their clinical 
usefulness. In particular, these compounds have been suggested to significantly 
inhibit the metabolism and excretion of cytotoxic agents, thus leading to 
unacceptable toxicity that has necessitated chemotherapy dose reduction in 
clinical trials (reviewed in Thomas and Coley, 2003) The development of more 
potent and selective P- gp inhibitors remained a goal, which has resulted in the 
discovery of a potent and a specific P- gp inhibitor, anthranilamide based, 
XR9576 (Xenova Ltd, Slough, UK) (Roe et al, 1999). 
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1.2. Apoptosis 
Cells that die accidentally as a result of an injury degenerate by a process called 
necrosis that is characterised mainly by swelling and bursting of the cells, which 
would together induce an inflammatory response in the surrounding tissue. 
Apoptosis on the other hand was the term first described by Kerr et al (1972), but 
the authors were grateful to Professor James Cormack of the department of 
Greek at the University of Aberdeen, who suggested the name. Apoptosis was 
suggested as a genetically regulated process, mechanisms of which appear to 
play a complementary but opposite role to mitosis in the regulation of cells in the 
animal and plant kingdom as examples. Kerr et al (1972) first described the 
changes in morphology in apoptotic cells as being of a "programmed" nature, 
initiated by stimuli such as the environment. These structural changes were 
suggested by the authors to take place in two stages, the first comprises a 
nuclear and cytoplasmic condensation, and breaking up of the cell into 
membrane-bound 'apoptotic bodies. The second stage involves the apoptotic 
bodies shedding from the surfaces. 
Apoptosis seems to be involved in the cell turnover in many healthy adult tissues 
and is responsible for the focal elimination of cells during the normal embryonic 
development. It can occur spontaneously and has been implicated in 
physiological atrophy of various tissues and organs (Kerr et al, 1972). 
Programmed cell death is a highly regulated process but has been described as 
a "double-edged" sword (Hughes and Mehmet, 2003). It is crucial to the 
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developmental processes in multi-cellular organisms, but loss of regulatory 
control is implicated in a growing number of diseases, including inflammation, 
malignancy, autoimmunity and neurodegeneration. Apoptosis-related genes 
have been identified in most tissues and successful characterisation of such 
genes presents potential therapeutic targets. Many of today's medical conditions 
can be attributed directly or indirectly to the defects in the regulation of apoptosis 
that result in either cell accumulation, in which cell eradication is impaired, or cell 
loss, in which cell-suicide programme is inappropriately triggered. Identification 
of these genes and gene products has provided the foundation for a range of 
drug discovery programmes, in particular in the development of 
chemotherapeutic agents to cause apoptosis in otherwise "immortal" cancer 
cells. 
1.3 Thesis aim and structure 
In the three cases described above - P-gp and non-P-gp mediated MDR, and 
apoptosis - the cellular processes are characterised by changes in the ionic 
state of the cells, as well as changes in the physiology of the membrane. This 
thesis sets out to study these phenomena using a technique known as 
dielectrophoresis (DEP). DEP is an electrostatic phenomenon which has been 
increasingly used for cell analysis since its discovery in 1951 by Herbert Pohl. 
By studying the motion of cells when exposed to electric fields of different 
frequency, it is possible to determine the electrical properties of those cells, and 
1.9 
in combination with conventional cell biology techniques, to come to a new 
understanding of these cellular processes. 
Although DEP has been used to study cancer cells in the past (Gascoyne et al, 
1992; 1993; 1997; Cristofanilli et al, 2002; Wang et al, 2002), these studies have 
mainly concentrated on the cellular membrane rather than the cell and its 
components in entirety. This thesis aims to investigate the dielectric properties of 
the whole cell (and particularly the cytoplasm), as well as studying differences in 
P-gp mediated MDR with respect to drug sensitive cell lines (Chapter 3) and 
non-P-gp mediated MDR (Chapter 4), and to provide and clarify the principles of 
MDR by understanding the cellular physiology. DEP is also used as part of a 
novel approach to study the biophysical changes during different stages of 
apoptosis (Chapter 5). All of these results indicate that DEP can both reinforce 
and extend existing knowledge of key processes in MDR and cancer. 
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2. Dielectrophoresis 
2.1. Introduction 
AC- electrokinetics is the collective term used to describe a group of phenomena. 
such as dielectrophoresis (DEP) and electrorotation (ROT). The motion of 
suspensoid particles resulting from polarisation forces produced by an 
inhomogenous electric field was first described and termed dielectrophoresis by 
Herbert Pohl (1950). He determined that this phenomenon was related to the 
related phenomenon of electrophoresis, in which suspended particles are moved by 
the action of an electrostatic field on the charged particles. 
If a dielectdc particle (such as a cell) is suspended in an electdc field, it will polarise 
and acquire a dipole. The direction and magnitude of this induced dipole depends 
on the frequency and magnitude of the electric field and on the dielectric properties 
of the cell and the medium (Pohl, 1978). Historically, the use of non-uniform electric 
fields was suggested by Pohl to have dated back to the 19t" century, when Lowden 
in 1891 patented an invention for the removal of metal particles from used 
lubricating oils. The DEP phenomenon was widely applied, later on, to the 
manipulation, separation and analysis of cellular and viral particles (Jones 1995, 
Zimmermann and Neil 1996, Hughes 2002). 
Particles expedencing such forces can be made to exhibit a vadety of motions 
including attraction to, and repulsion from, regions of high electric field (termed 
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positive and negative DEP respectively) by changing the frequency of the applied 
electric field. Pohl (1978) described how bio-particles such as bacteria, cells or 
viruses can be characterised by their dielectric properties, and since then 
dielectrophoresis can be used to distinguish between different types of bacteria 
(Markx et al, 1994a), to detect changes in cell cytoplasmic properties 
(Mahaworasilpa, 1994) and to detect whether cells are viable or non-viable (Ying et 
al, 1992; Falokun et al, 2003). The main factors influencing the dielectric properties 
of a bioparticle are the surface charge, the membrane capacitance and the 
conductivity of the cytoplasm. If drugs such as antibiotics change any of these 
factors, the dielectric properties of the cell change and can be detected (Johari et al, 
2003); this change can then be used to distinguish between cells that are resistant 
or sensitive to a drug. 
By exploiting the fact that different particles may experience forces acting in 
different directions when all other factors are the same, researchers have been able 
to use DEP to analyse and separate mixtures of cells on electrode arrays. For 
example, work has demonstrated that DEP can be used to examine the effect of 
drugs on cells, such as the effect of nystatin on erythrocytes (Gimsa et al. 1994) or 
the response of neutrophils to activation by chernotactic factors (Griffith and Cooper 
1998). Since populations of particles may expedence forces acting in different 
directions within specific frequency windows, separation has been demonstrated for 
mixtures of viable and non-viable yeast cells (Markx et al 1994b), and CD34+ cells 
from bone marrow (Stephens et al 1996), which can be separated from human 
blood. Other demonstrations of cell separation have been made in separating breast 
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cancer cells from blood, erythrocytes with and without malarial parasite infection, 
leukocytes, and different types of viruses in solution using this technique (Gascoyne 
et al 1997; Yang et al 1999; Morgan et al 1999), respectively. 
DEP can be used to determine the dielectric properties of particles by examining the 
behaviour of particles across a broad frequency range. This typically involved the 
determination of a frequency where the dielectrophoretic force on a particle is zero, 
and hence determining the dielectric properties of the membrane (Burt et al, 1990) 
This method has been applied to studies of cellular responses to a broad range of 
toxicants (Ratanachoo et al, 2002), membrane changes during apoptosis (Wang et 
al, 2002), malarial infection (e. g. Gascoyne et al, 2002) and cancer cell 
transformation (Huang et al, 1996). Studies of the dielectrophoretic behaviour of 
cells over a broader frequency range have elicited information about both 
membrane and cytoplasm, and have been used to examine the effects of antibiotics 
on bacteria (Johad et al., 2003), the effects of copper sulphate on algae (HCjbner et 
al, 2003). This potentially makes DEP a very valuable tool for screening 
applications. 
In order to extract dielectric parameters from dielectrophoretic data, modelling 
techniques are used to find best-fit parameter for given sets of data indicating the 
time-dependent polarisibility of the particles. Analytical expressions have been 
derived for the dielectrophoretic behaviour of homogeneous spheres (eg Benguigui 
and Lin 1982). However, it is generally considered (Jones 1995) that the expansion 
of the equation linking the dielectrophoretic behaviour to the dielectric properties of 
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the particle is too complex to provide useful analytical expressions directly linking 
the dielectric properties of the cell to the observed dielectrophoretic behaviour. In 
general, the estimation of dielectric properties is performed by best-fit numerical 
analysis (Huang et al 1996) in order to determine the properties of the membrane 
and the cytoplasm to provide information of potential significance to biological 
scientists. 
2.2. Theory 
A polarisable particle suspended in a uniform electric field (as shown in Figure 2.1A) 
will experience no net movement, as the forces induced by the interaction between 
each of the dipolar charges and the electric field are equal and opposite; the cell will 
not move unless it cardes a net charge. Even when there is a net charge, the 
particle will not undergo observable displacement unless the field frequency is equal 
to, or near, zero. 
The interaction of the charges on each side of the dipole with the electric field 
generates a force. Coulomb's law states that a charge Q, generates an electric field 
E, and that this electric field induces a force on second charge Q2 according to the 
following expression (equation 1): 
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E= r 4j2 
(1) 
F= Q2E 
where d the distance between the charges, r is the unit vector directed from Q, to 
Q2, and c is the permittivity of the material surrounding Q2. 
If there is an electdc field gradient across the cell, the magnitude of the forces on 
either side of the cell will be different. The cell will thus experience a net movement 
(Figure 2.1 B), in the direction of increasing field strength. 
A 
+ 
B 
± 
Net force 
Figure 2.11: A cell suspended in (A) a uniform field (B) a non-uniform field 
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The particle will always move along the direction of greatest increasing electric field 
regardless of the field poladty; the dipole will re-orient itself with the applied polarity 
(AC or DC fields), and the force is always governed by the field gradient rather than 
the field orientation. This force is termed dielectrophoresis (DEP). 
DEP can be further classified by direction (Jones, 1995). If the particle is more 
polarisable than the surrounding medium, it will experience a phenomenon called 
positive DEP, where cells are attracted to the electrodes. Its opposite effect, where 
cells are repelled from the electrodes, is called negative DEP. Whether a particle 
experiences positive or negative DEP is governed by its polarisibility relative to the 
suspending medium. It is the positive dielectrophoresis phenomenon that is used in 
this work. 
The dielectrophoretic force, FDEp, acting on a spherical body can be used to obtain 
parameters such as permittivity and conductivity. The time-averaged force exerted 
on a spherical particle of radius r suspended in a medium of relative permittivity F-r 
and exposed to an electric field gradient is given by equation 2: 
FDEP = 2xcO'crr 
3 Re[K(o))IVE 2 (2) 
where VE2is the gradient of the strength of the applied electric field squared and 
Re [K(o))] is the real part of the Clausius-Mossotti factor given by equation 3: 
2.6 
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K(w)= 
6* 2£ * pm 
(3) 
where ep and em are the complex permittivities of particle and medium respectively, 
given by equation 4: 
. 
(Ti 
Ei --.,: -'i j 
0) 
where . 6, and cr, refer to the (real) permittivity and conductivity of material i. 
(4) 
Characterisation of cells is made on the basis of physical phenomena occurring 
inside the cell, such as changes in conductivity (which reflects the ability to carry the 
electric charge) and permittivity (reflecting the ability to store the electric charge), for 
both cytoplasm and the membrane. Where the particle, rather than being 
homogeneous, consists of a shell surrounding a homogeneous core (as shown 
schematically in Figure 2.2, a more complex model is required). As described by 
Huang (1992), the smeared-out sphere approach can be used to determine the 
effective frequency dependent complex permittivity of multi-shelled particles. We 
can replace the complex permittivity with an effective value combining the properties 
of the shell and the core, thus: 
2.7 
3 
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r Ei 2 
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(5) 
where subscripts 1 and 2 correspond to the core and shell, and r, and r2 are the 
radii from the centre of the sphere to the inside and outside of the membrane, so 
that the Clausius-Mossotti factor for the ensemble is given by equation 6-. 
EI 
eff - 
S3 
K(a» =*2* 
Eleff + 63 
639ý73 
(6) 
Figure 2.2: A schematic of a single shell model, showing the shell surrounding a core, and 
suspended in a dielectric medium. The inner and outer radii of the membrane have values r, and r2 
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Where the subscript 3 refers to the suspending medium. If the full expression for 
Re[K(o))] is expressed analytically, it is sufficiently complex to render direct 
mathematical analysis hopelessly complicated (Jones, 1995); instead, researchers 
have used numerical methods to determine dielectric properties by analysis of 
dielectrophoretic spectra. Where analysis of dielectrophoretic data have been 
analysed (e. g. Gascoyne et al., 1997) by simplifying the solution using assumptions 
and by examining a number of crossover spectra as a function of medium 
conductivity. However, such methods are limited, particularly where the sample of 
cells precludes the repeating of sample analysis or where multiple populations are 
present. 
A given sphere, where the shell is of relatively low conductivity compared to the 
inner compartment and outer medium, has a polarisibility spectrum of the type is 
shown in Figure 2.3. 
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Figure 2.3:. A typical spectrum showing the relative polarisibility (Re[K((o)]) of a single-shelled 
particle as a function of frequency. Note the three plateaus at low frequency (negative DEP), 
intermediate frequencies (positive DEP) and high frequency (negative DEP). The transit between 
these plateaus takes approximately 1 decade; the lower and upper crossover frequencies, where 
Re[K((o)]=O, are indicated by Fxj and Fx2 respectively. 
This displays two characteristic dispersions, one rising at lower frequency and one 
falling at higher frequency. The frequency where the polarizibility crosses from 
negative to positive for a homogenous sphere allows the direct determination of the 
properties of the sphere from equation (3) by equating it to zero; however, for a 
shelled sphere the expression is much more complicated. Some work has been 
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performed in deriving expressions for the lower crossover frequency, but the upper 
frequency has largely been ignored because of limitations vvith signal generation 
equipment, as the upper crossover frequency is typically up to an order of 
magnitude higher than the maximum frequency of most signal generators. 
Benguigui and Lin (1982) demonstrated that it is possible to determine an 
expression for the low frequency crossover of a homogeneous sphere of 
conductivity and permittivity ep and (: Yp respectively; this was extended by Huang et al 
(1996) to consider the low-frequency crossover of a shelled sphere by considering it 
to be equivalent to a homogeneous sphere of effective conductivity and permittivity 
of: 
r2 
46p 62 
(T-2- 
-ri 
a (T r2 
p2 
(-r2-ri (7) 
Using this approximation, Huang and co-workers produced an expression for the 
low-frequency crossover Fxj: 
122 Iuu -A 
2u2 
F1 
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xi 27v ýA 2S2 -A -2 
2 
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(8) 
Where A= that is, the ratio of the radius of the cell to the thickness of the 
membrane. 
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At low frequencies (reviewed by Pethig, 1991), the total current comprises a surface 
current around the cell, plus a bulk membrane current, both having radial and 
tangential components. The overall conductivity of the particle has an additional 
term given by: 
up = Oýpbulk + 
2K, 
r 
(9) 
Where apbulk is the bulk conductivity of the cell membrane, Ks is the surface 
conductance and r is the cell radius. 
It is known that for the majority of cells, the thickness of the membrane is 
considerably smaller than the radius of the cell; that is, the ratio a= (L2 Y has a value ri 
very near 1. If we make the approximation a=l, we find that the high-frequency 
crossover frequency Fx2is given by the following: 
F-I x2 - 2; r 
222 
al - CIC3 - C3 
2e32 
- -I c3 - 812 
(10) 
Numerical studies of the output of the full expression indicate that this 
approximation holds for the upper crossover frequency for a wide range of electrical 
values provided a<1.15 (approx), corresponding to a ratio of cell radius to 
membrane thickness of 20: 1. Within this limit, which represents all cases of 
biological cells, equation (10) holds. The only case where the equation does not 
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work is where no upper crossover exists, which happens when el>, 63 (meaning the 
real part of the Clausius-Mossotti factor remains positive for all frequencies above 
Fxj) or u, <q3 (meaning the real part of the Clausius-Mossotti factor never has a 
value greater than zero). The former is a highly unlikely event in biology, and the 
latter can be controlled by the use of low-conductivity media. Provided these 
conditions are not met, 61 and q3 have very little effect on Fx2. Since the upper 
crossover frequency is independent of size, largely independent (in biological cells) 
of cytoplasmic permittivity or membrane properties, and of the remaining variables 
those relating to the medium can be precisely defined, Fx2 provides a direct 
measurement of the cytoplasmic conductivity. 
This result is significant for determining the upper dispersion characteristics. 
Although the actual crossover frequency is often too high to be observed with 
conventional function generators, the behaviour of the dielectric dispersion - taking 
approximately one decade to transit between stable plateaux of Re[K(w)] - means 
that the frequency at which Re[K(co)] begins to decline is also dependent only on a,. 
This can be extended to multiple populations, as described in Chapter 5; the 
presence of multiple upwards- or downwards- pointing dispersions can be related to 
the presence of multiple populations, where the downwards- pointing dispersions 
(with increasing frequency) points to populations categorised solely by their 
cytoplasmic conductivities. 
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2.3. DEP for biological characterisation 
The first application of DEP to living cells was described by Pohl and Hawk (1966), 
where they described the first means of physically separating live and dead cells. 
Since then, DEP and related phenomena have been shown to be useful in a variety 
of biological systems, including algae (HCjbner et al, 2003), bacteria (Markx et al, 
1994), yeasts (Huang et al, 1992) and mammalian white blood cells (Yang et al, 
1999) and red blood cells (Gimsa et al, 1996). The use of DEP in treating aqueous 
suspensions of cells or organelles is generally restricted to using altemating electric 
(AC) fields rather than static fields as applied to electrophoresis, which is a major 
point of difference in the two techniques (Pohl, 1978); this is because in AC fields 
the average displacement due to the electrophoretic force component to zero. 
Without a model of the behaviour of complex bioparticles such as cells, Pohl (1978) 
interpreted positive DEP behaviour in the light of known biophysical properties of 
cells. Working on the assumption that positive DEP was driven entirely by a particle 
having greater permittivity than the medium, he described how water is a high polar 
material, and as such will be pulled strongly toward the region of highest field 
intensity by the nonuniform field. If the cell was to move to the region of highest field 
intensity, it must therefore exhibit an even higher specific polarisibility. Pohl 
described a number of ways the cellular system can attain this high polarisibility. 
First, the cell itself is largely water, second, there are dissolved intracellular regions 
of numerous polar molecules-proteins, sugars, DNA and RNA, all of which can 
contribute to polarisation. Third, there are structured regions that can act as 
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capacitative regions, e. g. lipid membranes across which electrolytes can act to 
produce charge distributions. Fourth, there are structured areas in the surface 
where ionic double layers can produce very large polarisations. As frequency 
increases, the conductivity of membrane and cytoplasm also make important 
contributions. Since that time, it has been shown that Maxwell-Wagner interfacial 
polarisation is the dominant source of dipolar polarisation, meaning that conductivity 
and surface charge can also play a signfficant role in determining polarisibility (e. g. 
see Hughes, 2002 for explanation). 
The first successful experiments reported of the use of DEP to collect living cells 
were by Pohl and Hawk (1966). The authors used very simple equipment -a voltage 
supply, a pair of small, bare wire (pin), plate electrodes and a microscope. They 
showed that yeast (S. cerevisiae) could be made to collect at a reliable rate in the 
region of highest field intensity. Other yeast work was carded out using different 
configurations, such as the pin-pin design shown in the schematic diagram (Figure 
2.3) below, and used in this thesis. 
Figure 2.3: A schematic diagram of the pin-pin electrode configuration 
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In the early period of DEP study, no adequate model existed for explaining 
frequ ency-d epen dent DEP behaviour of complex bioparticles, so empirical studies 
were performed using DEP and yeast cells by varying the experimental conditions 
and observing the effect on the number of cells collected. This was measured as the 
average length of the pearl chain groups of cells attached to the electrodes after a 
particular time of collection. From this, the dielctrophoresis collection rate (DCR) 
was obtained, defined as the yield per unit time. The units of yield were divisions of 
the reticule of a microscope eyepiece (1 division corresponding to an object length 
of 10.3 jim). Physical parameters varied included voltage, cell concentration and 
frequency and conductivity (Pohl, 1978). The response of the cells was found to be 
approximately linear with that of voltage, but at much higher voltages, the yield was 
reduced. This reduction was suggested to be primarily due to the 'stirring' effect 
(now called electro-thermal flow), which results from the application of intense fields 
in free liquids. When the stirring is moderate it brings in more cells close to the pins 
where they can be more readily collected by the strong field gradient on the pins. At 
higher voltages, this effect becomes so strong that the flow becomes turbulent and 
prevents cells from reaching the electrodes, hence reducing the yield. The yield was 
also found to be linear with the cell concentration. The overall results (Pohl, 1978) 
concluded that voltage, concentration and time elapsed affect the yield more or less 
independently of other variables, whereas frequency and conductivity were strongly 
coupled, where one must be specified before the effect of the other can be given. 
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Other experiments with yeast cells involved investigating the effects of external 
agents on collection of cells. The biological parameters investigated included colony 
age, heat treatment, exposure to UV radiation and treatment with herbicides. Pohl 
and Hawk (1966) noticed that the organisms were greatly affected by heat, and 
demonstrated that heat-killed (or autoclaved) yeast cells could be physically 
separated from the living by DER DEP yield of yeast cells, that had been irradiated 
with UV light, has been studied. After treating the cells at a wavelength that was 
believed to have inflicted nuclear damage, DEP results showed that selective UV 
treatment did not affect the polarisation responses of cells. DEP has also been 
exploited in the study of herbicides to determine the effectiveness of the herbicides 
tested (as reviewed in Pohl, 1978). 
To examine the effect of ageing yeast colonies (S. cerevisae), samples from 
different incubation periods were compared by Pohl and Crane (1971) using DEP 
over a range of frequencies (102 _1 07 Hz). When relatively high solution conductivity 
was used, the very old cells had a slightly higher yield at low frequencies, and a 
slightly lower yield at high frequencies. The younger cells differed from the older 
cells by exhibiting no collection at 100 Hz. 
Further early DEP studies included comparing canine blood platelets, or 
thrombocytes from normal male and female dogs, and their Factor Vill deficient 
counterparts (reviewed in Phol, 1978). The yield DEP spectra were compared, and 
moderate differences in the polarisiblity of normal and various haemophilic type 
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blood platelets were observed, and bacteria such as flavobactedum, and E. coli, P 
aeruginosa, B. megaterium and B. cereus (reviewed in Pohl, 1978). 
In the 1980s, DEP research concentrated primarily on two aspects; the search for a 
model capable of accurately predicting DEP response, and further exploitation of 
the technique for biological applications. One such application was the use of DEP 
to bring cells together for electrofusion (reviewed in Zimmermann and Neil, 1996). 
Other applications, pursued largely by Dimitrov and colleagues saw DEP applied to 
characterisation of a range of cell types myelomas, hybridomas and lymphocytes B 
(Stoicheva and Dimitrov, 1986a), red blood cells (Tsoneva and Dimitrov, 1986), and 
white blood cells (Stoicheva and Dimitrov, 1986b), among others. During this 
period, the discovery of electrorotation by Arnold and Zimmermann (1982a) allowed 
a second electrokinetic method of cell analysis; this was applied for the 
measurement of membrane capacitance of single mesophyll cells in avena-sativa, 
(oats), and the rotation of a single cell in a rotating field (Arnold and Zimmermann 
1982a, b). Subsequent work used ROT to determine the dielectric properties of 
shelled spheres such as cells using theory developed by Fuhr and others (reviewed 
in Arnold and Zimmermann, 1988). 
In the 1990s DEP research expanded dramatically due to a number of factors. 
First, the "smeared-out" multi-shell model (originally developed by Hanai et al, 
1960), then by Irimajiri et al (1979) and later applied by Huang et al. (1992), 
supplanted earlier methods of determination of electrical properties, allowing DEP 
and ROT data to be interpreted more readily. For example, Chan et al (1997) used 
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multi-shell models to describe the electrokinetic behaviour of liposomes, and they 
demonstrated that the information provided by DEP and ROT yielded values of 
dielectdc parameters of liposome-like particles. Second, application of 
microengineering to the production of microelectrodes allows easy and direct 
observation of cell DEP in any lab. Finally, the growth of the "lab on a chip" 
movement brought an increase in interest in microengineered analysis and 
separation devices, particularly those with potential commercial applications. 
Positive and negative DEP were first demonstrated on microelectrodes in 1992 by 
Pethig et al and Gascoyne et al. The former group used yeast cells to show that 
collection arising from both positive and negative DEP was facilitated using the 
castellated electrode geometry, and the two forms of collection differed significantly 
as functions of the frequency of the applied non-uniform electric field and of the 
conductivity of the suspending medium. The latter group (Gascoyne et al, 1992) 
used positive and negative DEP to characterise normal, leukaemic and 
differentiation-induced leukaemic mouse erythrocytes as a function of frequency in 
the range 5A 02_1 05 Hz, which were shown to be significantly different. The group 
also demonstrated that by choosing the suitable frequency and cell suspension 
medium, DEP could be used to separate these cells. 
DEP was also used as a characterisation technique where the dielectric properties 
were used to provide the basis of subsequent separation work. For example, the 
effective electrical conductivity values for Gram-positive and Gram-negative bacteria 
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were determined in the frequency range (10 kHz- 100 kHz) (Markx et al, 1994a), 
where this information enabled experimental conditions to be selected to separate 
different microorganism species using DEP 
Another example where DEP and ROT were used in combination was that by 
Huang et al (1996), as the two techniques were used to determine the dielectric 
properties of a clone of normal rat kidney cells, which exhibited a transformed 
phenotype at 330C and a non-transformed phenotype at 39T. DEP measurements 
of the crossover frequency (at which cells experienced zero force) as a function of 
the suspension medium revealed that, in response to a temperature shift from 33"C 
to 39T for 24 hours, a significant decrease was observed in the specific membrane 
capacitance and conductance. ROT analyses demonstrated a similar reduction in 
the membrane capacitance but showed insignificant changes in the internal 
conductivity. The changes observed in the membrane dielectric properties and the 
membrane specific capacitance was correlated with cell membrane surface or 
morphology complexity, as confirmed by scanning electron microscopy. Other 
studies have considered the assessment of biocide action on bacteria[ biofilms 
(Zhou et al, 1995), for the detection of toxic chemicals. 
The use of DEP towards the mid and late 1990s showed an increased interest in the 
microbiology field. Quin et al (1996) investigated this technology for the rapid 
analysis of ozonated Cryptospotidium parvum oocysts, where two key frequencies 
were used for DEP collection (100 kHz and 10 MHz) to compare the effects of 
ozonation at various dosages. A consistent pattern was suggested between 
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increasing the ozone dose and a decrease in oocyte internal conductivity, as 
supported using a multi-shell mathematical modelling of spheres. The use of DEP 
as part of microbial analysis included characterisation of microbes in water (Betts 
and Brown, 1999), where the cell collection spectra were determined and used as 
the basis for distinguishing different cell types. This analytical application was then 
suggested as a method of separation in microbiology. Water quality testing and 
healthcare in general have provided ideas for exploiting DER One study (Dalton et 
all 2001) investigated the electrical properties of two waterborne protozoan 
parasites, Giardia muds and Cyclospora cayetanesis, with the potential use of the 
technique as a rapid and a precise assay for the determination of parasite viability. 
A more recent study (HCjbner et al, 2003) suggested the potential use of DEP as a 
low-cost and a rapid method of testing water quality, as the authors used DEP for 
the dielectrophoretic measurements of fresh water algae Selenastrum 
capficomutum in the presence of different copper sulphate concentrations. 
One limitation of DEP for automated study is the requirement to observe cell motion. 
In the late 1990s, Suehiro et al (1999) described a new technique that realises the 
estimation of biological cell concentration in an aqueous medium. The group used a 
dielectrophoretic impedance measurement (DEPIM) method between two 
electrodes, and used positive DEP to capture cells on an interdigitated electrode 
system in pearl-chain formation. By monitoring the variations in the electrical 
impedance, cell populations were analysed quantitavely according to theoretical 
model of cell collection process, where a suspension of E. coli could accurately be 
assayed in about 10 minutes at 105/CM-3 concentration. In a more recent literature 
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source, Suehiro et al (2003) proposed a newer method to improve DEPIM sensitivity 
using an electropermeabilisation technique, which was applied after using DEP to 
trap cells in order to release intracellular ions. When high AC fields were applied 
across the trapped bacteria, an increase in conductance was observed, which was 
suggested to be due to electropermeabilisation. 
Since DEP allows the determination of drug action, it has potential for routine testing 
of the effects of drugs for pharmaceutical applications. A recent study (Johad et al, 
2003) described the application of DEP, to determine drug resistance by studying 
the dielectric parameters of Staphylococcus epidermidis. The results indicated a 
strong similarity between the dielectric properties of sensitive and resistant strains in 
the absence of antibiotic treatment, whereas there was a significant difference 
between the sensitive and resistant strains after treatment. 
Owing to the fact that DEP allows the non-invasive study of cells, to the obvious 
applications were in the analysis of human cells for potential medical applications. 
A number of approaches have been taken. One of which was the challenge of using 
DEP for the production of small and low cost automated devices for assessing 
parasite concentrations with potential drug sensitivity studies and diagnosis of 
malaria (Gascoyne et al, 2002). The other and most common approach was that of 
studying cancer, and is discussed in more detail later. 
Since DEP is most readily applied to suspended cells, the majority of work has been 
performed on blood cells. To this end, studies have been performed on the most 
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abundant cells in the blood, including erythrocytes (Minerick et al, 2003), 
lymphocytes (Ermolina et al, 2000), leukocytes (Yang et al, 1999) and platelets 
(Neu et al, 2002). Furthermore, Chan and co-workers (2000) conducted a study of 
circulating trophoblast cells, which detach from the placental lining and enter the 
circulation during pregnancy, as a potential means of isolating and testing foetal 
DNA. 
2.4. Cancer studies using DEP 
Since cancer is a major cause of morbidity (as discussed in the previous chapter), it 
is the subject of extensive research across many disciplines. Although a broad 
spectrum of treatments have been developed, the determination of the prognosis 
and early detection is important; this is where DEP has potential applications. AC- 
electrokinetic techniques have been amongst the methods used to investigate 
cancer cells by ways of characterising them relative to their non-cancerous 
counterparts. Changes in the dielectric properties could potentially be used to 
separate cancer cells from blood. In this section, we will review how DEP and AC- 
electrokinetics have been used to characterise cancer cells, assess their behaviour 
before and after treatment, and to form the basis of techniques to separate 
cancerous from non-cancerous cells. The cellular biophysical properties can reflect 
cellular states such as differentiation and viability (Hu et al, 1990; Burt et al, 1990), 
and DEP-based manipulation of turnour cells have formed part of the lab-on-a-chip 
based devices in cancer research (reviewed by Gambari et al, 2003). 
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2.4.1. Characterisation of cancer cells 
The use of DEP for characterisation of cancer cells dates back to the 1980s, where 
it was used to characterise human malignant melanocytes (Mischel et al, 1983), 
myeloma and, hybridoma cells and lymphocytes (Stoicheva and Dimitrov, 1986a). 
The most recent application at time of writing was that of Cristofanilli et al (2002), 
where automated ROT was used to examine dielectric variations related to HER- 
2/neu overexpression in breast cancer cell sublines (MCF-7). The study evaluated 
the behaviour of MCF-7/neo and p185(neu) transfectants (MCF/HER2-11 and 
MCF/HER2-18) to investigate whether differences in HER-2/neu expression were 
associated with differences in dielectric properties. Western blots were used to 
assess the overexpression and the specific membrane capacitance was measured. 
The results suggested that ROT was sufficiently sensitive to detect variations in the 
dielectric properties in breast cancer cell lines overexpressing p185(neu), with the 
mean specific membrane capacitance being significantly different in MCF/neo from 
the other transfected sublines (MCF/HER2-11 and MCF/HER2-18). These 
differences were suggested to be related to the morphological alterations 
determined by HER-2/ neu overexpression. 
Many characterisation experiments have involved examining changes caused by 
treatment with different agents to assess the effect of the agent on these dielectric 
properties of cancer cells. An example of this was performed by Burt et al (1990) 
and co-workers, who used DEP to study the membrane changes accompanying the 
induced differentiation of Friend murine erythroleukaernia cell lines (DS19 and R1) 
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following treatment with hexamethylene bisacetamide (HMBA) and dimethyl 
suffoxide (DIVISO). These are agents that induce terminal differentiation in DS19, 
but not in Rl. The authors found that the membrane capacitance of DS19 was 
decreased by 30%, and the membrane conductivity to fall by a factor of five after 
treating DS19. No response was seen by R1 after treatment. They also found that 
the theoretical model was useful for comparing differences in the data, but also 
reported several significant discrepancies between predications and the 
experimental data observed, and suggested the discrepancies to be accounted by 
factors such as, surface charge effects and intracellular compartments. The same 
erythropoetic cifferentiation agent (HMBA) was later used (Wang et al, 1994) to 
investigate alterations in the plasma membrane of DS19 using ROT. Scanning and 
transmission electron microscopy revealed that the high membrane capacitance 
obtained for DS19 before treatment reflected the large area of plasma membrane 
associated with complex surface morphology, such as the presence of microvilli. 
Furthermore, ROT demonstrated that treatment with HMBA for 3 days resulted in a 
fall in the membrane capacitance, which correlated with a reduction in the density of 
microvilli. This work demonstrated that cells exposed to 72 hour of differentiation 
had an enhanced resilience relative to their untreated counterparts, and the authors 
suggested that this evidences the early stages of development of the membrane 
skeleton which becomes fully developed in mature erythrocytes. They highlighted 
the value of ROT as a non-invasive method for the characterisation of viable 
leukaemic cells and their responses to stimuli, and showed that membrane 
capacitance reflects membrane morphology. 
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A more recent study where the same principle, of using DEP to characterise the 
dielectric property changes following treatment with an agent, include the study by 
Wang et al (2002). DEP was suggested as a more sensitive technique to indicate 
membrane dielectric changes, in HL-60 induced apoptosis (programmed cell death), 
than the conventional flow cytometdc analysis of surface phosphatidylsedne 
expression or DNA fragmentation. The membrane capacitance was measured 
following 1 to 4 hours of incubations with genistein (GEN) - an apoptosis inducing 
agent. DEP was used in conjunction with annexin v assay, and the results showed 
a decrease in the membrane capacitance as the incubation period with GEN 
increased to 4 hours. Furthermore, the results were suggested to indicate that it 
might be possible to correlate changes in cell dielectric properties with very early 
stages of apoptosis and cell DEP characteristics as early and sensitive prognostic 
markers of apoptosis. The authors pointed to the applicability of DEP-based 
technology to rapidly detect, separate and quantify normal, apoptotic and necrotic 
cells from cell mixtures. Another study (Ratanachoo et al, 2002) employed DEP for 
the detection of cellular responses to toxicants. Paraquat, styrene oxide (SO), N- 
nitrosos-N-methylurea (NMU) and puromycin were used and chosen because of 
their different mechanisms of action, namely membrane free radical attack, 
simultaneous membrane and nucleic acid attack, nucleic acid alkylation and protein 
synthesis inhibition, respectively. For all treatments, membrane capacitance of 
HL60- cells decreased. The DEP responses correlated sensitively with alterations in 
cell surface morphology, especially microvilli and blebs, which were also observed 
by scanning electron microscopy. The study pointed to the DEP-based method 
being more sensitive to agents that had a direct action on the membrane than those 
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agents for which membrane alterations were secondary. Direct detection of DEP 
responses were found to be 15 and 30 minutes after exposure to agents that 
directly damaged membrane and those acted on the cell intracellular targets. 
Huang et al (1995) used ROT measurements to study the cytoplasmic dielectric 
properties of DS1 9 cells following HMBA treatment. After treatment, the DS1 9 cells 
exhibited a slight increment in the average interior permittivity and a decrement in 
the interior conductivity. Of significance was the average permittivity of cell interiors, 
which was larger than that of pure water (75 co). Using numerical simulations, the 
nuclear dielectric parameters were looked at to investigate the effects of nuclei on 
ROT spectra of intact cells, and the analysis subsequently considered other 
intracellular organelles such as mitochondria. The authors concluded the large 
permittivity observed did not result from cell nuclei or mitochondria, and instead may 
have arisen from the combined effects of cytoplasmic organelles. Finally, in order to 
assess whether DEP affects the cells exposed to nonuniform fields, Wang and 
Gascoyne (1999) used dielectrophoretic manipulations to investigate DS19 (murine 
erythroleukaemia). It was found that hydrogen peroxide was produced when sugar- 
containing media were exposed to fields outside the typical field strengths in AC- 
electrokinetics. The AC typical fields used for the dielectrophoretic manipulation and 
sorting of cells do not damage DS19 cells. 
2.27 
2.4.2. Separation of cancer cells 
The use of DEP as a separation technique in a cancer setting goes back to the early 
1990s. Gascoyne et al (1992) demonstrated the first use of DEP as a separation 
technique for cancer cells. The dielectrophoretic characteristics of normal, 
leukaemic and differentiation-induced leukaemic mouse erythrocytes were 
measured as a function of frequency and were shown to be significantly different, by 
selecting the appropriate frequency they were able to demonstrate positive and 
negative DEP of healthy and Friend murine erythroleukaemic cells. Since then, the 
majority of separators have been flow separators, either separating by flowing cells 
across an electrode array and trapping by positive DEP, or by using field-flow 
fractionation (FFF) (Markx et al 1997), where cells are repelled and are sorted 
according to the height they are repelled to (and hence the speed at which they 
flow). These two schemes are shown in Figure 2.4. 
The most common form of flow separation is that of using positive and negative 
DER In 1995, the first work on separation of human cancer cells was published 
using this method. At the time, a considerable biomedical and clinical interest in 
isolating cell subpopulation of bone marrow (BM) and peripheral blood stem cell 
collections (PBSC) emerged. These collections contain haemopoietic stem cells 
required for bone marrow reconstitution. The CD34+ antigen was used as a marker 
to identify haemopoietic precursor cells, which were strongly expressed in the 
primitive cells, but lost in differentiated cells. The limitation of detecting this antigen 
is that it is expressed on 14% of BM and PBSC. DEP investigations were carried 
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out during this time period to study the dielectrophoretic separation and enrichment 
of CD34+ subpopulation from BM and PBSC (e. g. Talary et al, 1995). The results 
indicated that maximum enrichment of stem cells (of 4.9 fold) occurred at a 
frequency of around 5 kHz. A follow-up CD34+ enrichment study (Stephens et al, 
1996) used DEP for isolating CD34+ cell populations from leukaemic patients 
undergoing peripheral blood stem cell harvests. The study pointed to the limitations 
of the conventional techniques that rely on the use of antibodies specific to the 
surface marker CD34+ as being expensive and time consuming, and therefore used 
DEP as a tool to separate CD34+ cells, as it does not rely on cell-specific markers. 
The results indicated that a maximum enrichment was obtained in the region of 10- 
20 kHz. 
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Figure 2.4: Two common forms of DEP flow separation. (A) When particles from different 
populations flow across an electrode, conditions can be chosen for one population to be trapped on 
the electrodes (shown red) whilst the other (green) experiences negative DEP and is flushed out. (B) 
In DEP-FFF, both populations are repelled by negative DEP, but by different amounts; this causes 
them to travel at different heights above the electrodes, and hence at different speeds. Particle flow 
in both figures is from left to right. 
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The research team which has advanced the field of DEP separation for cancer 
diagnosis is that of Becker, Gascoyne and co-workers (1994), who used a flow cell 
and castellated electrode array (which they termed a "dielectric affinity column"), 
usually in conjunction with electrorotation for cell analysis. Interdigitated 
microelectrode arrays were used to retain human promyelocytic leukaemic cells 
(HL-60) from blood collected from venipunctures in a ratio of 3: 2. HL-60 cells could 
subsequently be released by removal of the dielectrophoretic field and collected, 
while normal blood cells were eluted from the electrode chamber. This work on 
separation of cancer cells from blood was further explored by the same group 
(Becker et al 1995) to demonstrate that the dielectric properties of metastatic human 
breast cancer cell line MDA-231 were significantly different from those of 
erythrocytes and T-lymphocytes, and the differences were exploited to separate 
breast cancer cells from normal blood cells. Gascoyne et al (1997) continued the 
work on dielectrophoretic separation of cancer cells from blood. The 'dielectric 
column' was used to separate and harvest viable HL-60 and MDA-231 from whole 
blood. They concluded that cell surface morphology coupled with cell size, 
dominated cell dielectrophoretic responses and acted as a sorting criterion. They 
have also recommended this technique for research areas where cell modification 
(such as that by stain or antibodies) may compromise the results, or where specific 
markers or antibodies might not be available. Furthermore, since the parameters by 
which cells are identified in current sorting and charactedsation technologies, such 
as fluorescence- activated sorting, affinity column and centrifugal techniques play 
little or no role in AC- electrokinetics, they suggested the dielectrophoretic affinity 
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column approach might be applied as an adjunct to the conventional methods to 
yield an overall improved discrimination. 
The use of FFF for cancer studies has also been pursued by Gascoyne and co- 
workers. One example, used to separate cancer cells from stem cells, was 
performed by Huang et al (1999) by exploiting a combination of fluid flow and DER 
DEP-field flow-fractionation (DEP-FFF) was used to purge human breast cancer 
MDA-435 cells from haemopoietic CD34+ stem cells. A chamber with an array of 
interdigitated microelectrodes was used to generate DEP forces that levitated the 
cell mixture in a fluid flow profile. The CD34' cells were levitated higher and were 
carTied faster by the fluid flow, earlier than the MDA-435. Using this set up as well 
as on-line flow cytometry, efficient separation of the cell mixture was observed in 
less than 12 minutes, with CD34+ cell fractions being more than 99% pure. The 
authors suggested the potential usefulness of DEP-FFF in biomedical cell 
separation problems, including microfluid-scale-based diagnosis and providing a 
preparative-scale purification of cell subpopulations. 
Other groups are exploring new methods of cell separation for cancer applications. 
For example, a novel use of cell levitation was investigated later by a different group 
(Altomere et al, 2003), where they described the use of an innovative printed circuit 
board (PCB) device to generate DEP-based. This was used to create software- 
controlled "cages" that can be moved to any place inside the microchamber, and 
entrap cells according to their dielectrophoretic properties. Different tumour cell lines 
were used, including Jurkat (T-lymphoid), erythroleukaemic (HEL) and melanoma 
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(Colo38). The electrode array was suggested to form the basis for a lab on a chip) 
performing cell separation the basis of DEP levitation and movement of different 
tumour cells under different DEP conditions. 
2.5. Conclusion 
Dielectrophoretic methods have been studied for over four decades, and extensively 
so from the 1990s. It has employed a wide range of applications, and in different 
fields and hosts, such as plants, bacteria and viruses, as well as different 
mammalian systems, in particular those including samples of human origin. DEP 
has been used to move, trap, sort and separate, and analyse cells on the basis of 
characterising cells under different conditions, be it change of environment or drug 
treatment, the general aim has always involved obtaining a better understanding as 
to how cells or particles behave under certain conditions. Investigations like these 
have led the potential applications of DEP in areas like pharmacology, microbiology, 
oncology and some of which have made their way to commercial technology with 
many filed patents based on electrode design or a novel application. The most 
promising of all is the new merge of this technique, whether alone or in combination 
with others, into lab-on-a-chip systems. 
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3. Dielectrophoretic assessment of drug sensitive and 
resistant cancer cells 
3.1. Introduction 
During the lifetime of a cell, a number of and transport mechanisms are involved 
in regulating metabolism. These mechanisms include passive modes such as 
diffusion and facilitated diffusion, and active transport modes requiring energy 
expenditure. These are illustrated briefly in Figure 3.1. 
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Figure 3.11: A schematic showing ion transport mechanisms across a membrane. Small non-polar 
molecules Gan diffuse across the membrane (top); if the rate of transport by diffusion is 
insufficient, it can be assisted by transport proteins (middle). Finally, if the cell requires transport 
against a diffusion gradient, a pump is required (bottom). 
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The internal concentration of different species of ions and molecules are 
maintained in their correct numbers by these processes and membranes, as they 
regulate the passage of all substances moving in and out of the cell and between 
membrane-bound interior compartments, such as those at the vesicular level. As 
part of this maintenance, substances constantly move in both directions across 
the cellular membranes. Substances such as metabolites and raw materials 
enter the cell from the outside, while cell waste material moves in the opposite 
direction and is expelled from the cell. 
Ions constantly flow in both directions and between the different compartments in 
the cell interior. The two primary mechanisms that underlie the ionic transport in 
a cell are passive and active transport. The former simply depends on the ionic 
concentration inside relative to the outside of the cell; if it is more concentrated 
outside, then the movement of the ions will be from outside to inside, and vice 
versa. The movement of ions in this type of. transport relies on the concentration 
difference of inside of a cell relative to the outside; movement is driven by a 
concentration gradient. The passive transport of ions is therefore influenced by 
the charge and concentration differences on either side of the membrane. As a 
result, this type of transport requires no expenditure of cellular energy, i. e. it does 
not require ATP. On the other hand, active transport involves the movement of 
ions against their concentration gradients and therefore requires energy in the 
form of ATP. The cellular ionic concentration is maintained by coordination of 
both passive and active transport proteins. This is to ensure that the ionic 
concentration inside the cell remains at the required levels for cellular functions. 
3.2 
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3.1.1. Ion transport mechanisms 
There are many mechanisms by which ions are transported across the 
membrane. In order to understand the mechanisms which contribute to the ionic 
strength - and hence cytoplasmic conductivity - it is necessary to review the 
primary transport mechanisms of the principal ionic species present in the 
cytosol. These ions include sodium, potassium, hydrogen, calcium, chloride and 
magnesium. The major ionic compositions inside and outside of a typical 
mammalian eukaryotic cell are shown in the Figure 3.2. 
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Figure 3.2: the principal ionic composition of a typical mammalian cell, with more K+ 
Sodium (Na+) is pushed outward by the sodium/potassium (Na+/K+) pump, which 
operates by pumping 3 Na + out of the cell for every 2 K+ pumped in (the 
mechanism of which is shown in Figure 3.3). 
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Figure 3.3: A mechanism for the operation of Na+/K+ - ATPase pump. In (a) the pump binds 
and hydrolyses ATP, the phosphate group is transferred from ATP to the transporter protein. 
(b) The binding of phosphate converts the Na+ binding site to its high affinity state and will 
avidly bind to Na+ on the cytoplasmic side of the membrane. (c) The binding of Na+ triggers 
a conformational change that exposes the Na+ binding to the medium outside of the cell. 
(d) As the conformational change becomes complete, the Na+ binding site is altered to the low 
affinity state, this releasing Na+ to the outside medium. At the same time, the K+ binding site is 
activated to bind to the K+ in the outside medium with high affinity. (e) K+ induces a conformational 
change which exposes the K+ binding site to the cell interior and releases the phosphate group. 
At the same time, the K+ binding site is converted to low affinity state and K+ is released to 
the cell interior. (f) Completion of this step returns the transporter to the initial state, ready to repeat 
the cycle. The transporter works by having 3 Na + moved to the outside and two K+ to the inside of the 
cell for each turn of the cycle. (Picture taken from Wolfe, 1993). 
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The activity of this pump is the primary source of voltage difference across the 
plasma membrane of cells. Na' enters constantly through leakage across the 
plasma membrane by the activity of the Na'-driven cotransport pumps, and in 
excitable cells, through the voltage- and ligand- gated Na' channels. The usual 
inward traffic of Na' is counteracted by the Na'/K-ATPase active transport 
pump. 
Other studies (De Luise et al, 1980) demonstrated the importance of this pump in 
human red blood cells in relation to obesity. Reduced numbers of sodium pump 
units and reduced pump activity were found in red blood cells, suggesting that 
possible Na' pump abnormalities may contribute to the pathophysiology of 
obesity. 
The flow of K+ into a cell is usually controlled by the activity of the Na+/K+- 
ATPase and by indirect active transport. In order to maintain a high inside/low 
outside gradient (as shown in the Figure 3.3), the outward movement of K+ along 
this concentration gradient occurs passively through slow leakage across the 
plasma membrane and through the activity of voltage- and ligand-gated K+ 
channels, which occur in both excitable and non-excitable cells. The internal loss 
of K+ is usually counteracted, again, by the Na+/K+ - ATPase pump (Wolfe, 1993) 
Hydrogen ions (H+) are pushed out of the cytoplasm by the activity of the indirect 
active transporter that exchanges Na+ outside for H+ inside. This transporter is 
sometimes abbreviated to NHE. It functions to counteract for the constant 
production of surplus H+ by metabolic reactions. NHE are integral proteins found 
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in the membranes of all eukaryotic cells (Aharonovitz et al, 2001). NHE (isoform 
6) has been found in the recycling endosomes of cells (Brett et al, 2002). This 
exchanger operates by actively co-transporting anions, including Cl-, (P04)-l- and 
(S04)2- into cells for the exchange of Na' (Wolfe, 1993). It therefore helps to 
regulate the internal pH of the cytoplasm inside the cell. The other mechanism 
which controls the cytoplasmic pH is the removal of H+ by the V-type active 
transport pumps. This mechanism works in collaboration with the cellular 
trafficking system (Figure 3.4A), as the pumps push the H+ ions from the 
cytoplasm into vesicles such as the Golgi complex (and the trans-Golgi network, 
TGN), secretory vesicles and lysosomes. The activity of the V-type pumps 
simultaneously lowers the pH of the internal contents of these organelles and 
raises the pH of the surrounding cytoplasm. The increased acidity of the vesicles 
is critical to their functions in storage, in recycling during endocytosis and in the 
activation of the enzymes held by the vesicles (Wolfe, 1993). The cytoplasmic 
pH in most normal cells lies between 7.2-7.6; the pH of the nucleus ranges 
between 7.5-7.8, being around 0.3 pH units more alkaline than the cytoplasm 
(Seksek and Bolard, 1996; Altan et al, 1998). The cell cytoplasm also contains 
slightly more acidic organelles and vesicles, such as the Golgi, early endosomes 
and late endosomes (also called prelysosomal compartment). The pH ranges 
between 6.2-6.4 in the Golgi, 6.0-6.5 in the early enclosomes, 5.2-5.8 in the late 
endosomes, 5.8 in the secretory vesicles and 4.8-5.2 in the lysosomes (Seksek 
et al, 1995, Kim et al, 1996 and Schindler et al, 1996). Figure 3.413 shows an 
example of the pH values in different compartments of breast cells. 
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Calcium (Ca 2+) ions are removed from the cytoplasm by the activity of Ca 
2+ 
_ 
ATPase pumps in the plasma membrane and in the vesicles of the endoplasmic 
reticulum (ER). The mitochondria can take up and store large amounts of Ca 2+ 
by the formation of the inorganic calcium deposits in the mitochondrial matrix. 
The resultant Ca 2+ gradient, which is high in the cell exterior, in the ER and in the 
mitochondria, but low in the cytoplasm, controls a range of cellular mechanisms. 
The low Ca 2+ is maintained by the pumps that remove the ions from the 
cytoplasm. Sudden influxes of Ca 2+ , which could be triggered by a variety of 
systems, set the control mechanisms. Entry of the Ca 2+ could either be through 
the voltage- or ligand gated channels, and contributes to the generation of 
electrical impulses in nerve cells (Wolfe, 1993). 
Magnesium (Mg2+) is another important ion mainly involved in the function of 
enzymes, as it is an essential cofactor. It can also play an important role in the 
regulation of membrane transporters such as Ca 2" active transport pumps. Mg2+ 
has been suggested (Wolfe, 1993) to steadily and slowly leak out into most cell 
types from relatively high concentrations in the extracellular medium. Free 
cytoplasmic concentrations of Mg2+ are kept relatively low, through binding to 
cellular molecules such as ATP and RNA, and by the antiport system that is 
driven by the high outside/low inside Na+ gradient. As Na+ moves inward, the 
antiport pumps Mg 
2+ 
outward. 
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Figure 3A (A) A diagram showing a summary of the major membrane trafficking routes within the 
cell. The newly synthesised protein leaves the endoplasmic reticulum (ER) for post-transcriptional 
processing in the Golgi apparatus. The proteins are then transferred either to secretory vesicles or 
the pre-lysosomal compartments (called late endosomes). Proteins that are taken form the cell 
surface undergo a peripheral sorting in the early endosomes and part of the material is carried back 
to the cell surface. In other cases, the material is recycled and carried to the interior of the cell in 
transport vesides to the pre-lysosomal compartments, where it mixes with lysosomal enzymes from 
Golgi to form lysosomes. Since the volume of the membrane remains constant, endocytosis is 
balanced by the outward flow of protein-containing vesicles. (B) The pH values of different 
intracellular compartments in normal breast cells. (Altenberg et al, 1993, Seksek et al, 1995, Kim et 
al, 1996, Schindler et al, 1996, Seksek and Bolard, 1996, Altan et al, 1998 and Belhoussine, 1999 
and as reviewed by Larsen, 2000). (L= lysosomes, LE= late enclosome (or early lysosome), EE= 
early endosome, SV-- secretory vesicles). 
On the other hand, negatively charged ions (anions) can enter the cells by either 
passive diffusion or active transport. In cells, facilitated diffusion transporters can 
permit entry of anions, such as chloride (CI-), phosphate (P04)3- and sulphate 
(S04)2- 
. 
The same anions can also be actively pumped into cells by Na+ - driven 
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cotransport. Another member of the group of transporters that exchange anions 
across the plasma membranes is the chloride/bi carbonate (Cl-/HC03-) anion 
exchanger of erythrocytes and other cells. This exchanges extracellular Cl- for 
intracellular bicarbonate, 
It is the combined activities of passive and active transporters delivering anions 
to the cell interior complement the carriers that move positively charged ions 
(cations) in and out of the cytoplasm, so that cells have a significant surplus of 
anions in the cytoplasm. This unequal distribution of positive and negative 
charges produces the charge or voltage difference characteristic of living cells, in 
which the interior of the cell is negative relative to the exterior. This potential 
difference is referred to as membrane potential. 
The work of active transporters in maintaining cellular ion concentration at the 
appropriate level has a significant contribution to the total energy expenditure in 
the cell. As much as 20% of the heat used to maintain body temperature is 
generated by the transformation of chemical energy to heat as the active 
transporters move ions across the plasma membrane. The greatest consumer of 
these active transporters is the Na+/K+ -ATPase pump, which reflects its 
importance in controlling the osmotic balance and setting up the Na+ gradient 
used for cotransport (Wolfe, 1993). 
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3.1.2. Multidrug resistance and cellular ions and trafficking 
Multidrug resistance (MDR) is always multifactorial, but one or more than one 
mechanism can be present in one tumour cell. The mechanism of resistance, as 
reviewed in chapter 2 of this thesis, may be associated with decreased drug 
accumulation (decreased drug uptake and/or increased drug efflux) and altered 
intracellular drug distribution, or possibly due to the expression of the ABC 
transporters, (also known as ABCC gene family, including P-gp, MRP and LRP, ) 
(Dano, 1973; Juliano and Ling, 1976; Cole et al, 1992; Scheper et al, 1993; 
Gottesman and Pastan, 1988). This new nomenclature was developed by the 
Human Gene Nomenclature Committee (HUGO) in 1999. The ABCC family 
comprise other members such as sulfonylurea receptors (SUR) and the cystic 
fibrosis transmembrane conductance regulator (CFTR). Subsequent cloning 
characterised another transporter, the canalicular multispecific organic anion 
transporter (cMOAT) from rat (Ishikawa et al, 2000). 
The mechanism related to altered intracellular drug distribution is of main 
concern (as reviewed by Larsen et al 2000). Most anticancer drugs target the 
nucleus or DNA, so that sequestration of the drug in cytoplasmic organelles such 
as the trans-Golgi network (TGN), the recycling endosomes and lysosomes 
causes a decrease in drug target interaction and a decrease in cytotoxicity, even 
if the total intercellular drug concentration remains unchanged. Larsen and co- 
workers (2000) suggested that altered intracellular drug distribution is closely 
related to drug accumulation, making it difficult to separate the two processes, 
which seem to be the most common mechanisms of resistance in tumour cells. 
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- The other common modification in MDR cells is alkalisation of the intracellular 
pH. It has been reported (Roepe et al, 1993; Altenberg et al 1993; Seksek et al, 
1995; Kim et al, 1996; Seksek and Bolard, 1996; Altan et al 1998; Belhoussine et 
al 1999) that many drug resistant tumour cell lines show alterations in 
intracellular pH relative to the parent cell lines. Changes in internal pH gradients 
are associated with changes in drug distribution and sensitivity to anticancer 
agents. Figure 3.5A and B below show the differences in pH values that may 
occur in drug sensitive and drug resistant breast cancer cells, as an example. 
It has been noted that the intracellular pH was altered in tumour cells, such that 
the cytoplasm became more acidic, while the vesicular pH became more 
alkaline. The result was a greatly decreased intracellular pH gradient relative to 
parental cells. This defect was correlated with disruption in the function and 
organisation of the trans-Golgi network (TGN) (Altenberg et al, 1993, Schindler 
et al, 1996, Altan et al, 1998, Belhoussine et al, 1999). Treatment of doxorubicin 
resistant cells with ionophores that disrupt the acidification of the vesicles, lead 
to the re-sensitisation of the resistant cancer cell line, strongly suggesting a 
direct association between the intracellular pH gradient and drug resistance 
(Schindler et al, 1996, Altan et al, 1998). 
3.11 
rI 
o's 
40004-polgi 
N 
00 do 
40 00* 
00041IN 
4 f. - 
:& nucleus 
LE PH 7.1 
PH C6 
Doo PH 6.8 PH > &a 
9; ý. 
(B);; 
EE 
LE 
PH 6.0 
L oo 
PN, c " 
Colgi 
nuchms 
PH 7.2 , 
PH 7.1 
Figure 3.5: The pH values of different intracellular compartments of the parental drug sensitive 
(A) and MDR (B) breast cancer cells. (Altenberg et al, 1993; Seksek et al, 1995; Kim et al, 1996; 
Schindler et al, 1996; Seksek and Bolard, 1996; Altan et al, 1998; Belhoussine, 1999 and as 
reviewed by Larsen, 2000). (L= lysosomes, LE= late enclosome (or early lysosome), EE= early 
endosome, SV= secretory vesicles). 
It has been documented that the intracellular pH of mammalian cells was mainly 
regulated by Na+/ H+ exchange and HC03-dependent transport mechanisms. In 
addition, the vacuolar type H+ ATPase may have been expressed in some 
tumour cells (Marti nez-Zagui Ian et al 1993). An interesting study has shown that 
at least one subunit of the vacuolar proton ATPase was over-expressed in cells 
over-expressing P-gp. The results suggested an involvement of this ATPase in 
the drug efflux from resistant cells (Marquardt and Center, 1991). Over- 
expression of certain ABC transporters can be accompanied by increases in 
certain ion channels. MRP over-expression accompanied increases in both K+ 
and volume-regulated Cl- channel currents (JIrsch et al, 1993). On the other 
hand, P-gp has been proposed to function as a Cl- channel (Valverde et al, 
1992), while another study reported that P-gp was, rather, a channel regulator 
(Hardy, et al, 1995). This implies that the ABC transporters may participate in ion 
regulation, thereby modulating vesicular transport, as described by Larsen et al 
(2000). 
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ABC transporters are involved in the movement of a variety of molecules across 
membranes including the chloride, Cl- by the cystic fibrosis transmembrane 
regulator, CFTR. The function of P-gp in normal tissues has not been fully 
clarified (Pinedo and Giaccone, 1995). Studies with knockout mice lacking the 
mdrla gene (that codes for P-gp) demonstrated the importance of this protein in 
the blood-brain barrier and drug disposition (Schinkel et al, 1994). 
3.1.3. P-gp and multidrug resistance 
Multidrug resistance (MDR) is the simultaneous resistance of tumour cells to 
different natural anticancer drugs that have no common structure or function. 
Several mechanisms contribute to the MDR phenotype, a common correlate of 
MDR is the over-expression of an ATP driven membrane protein, P-gp (Figure 
3.6), as reviewed by Thomas and Coley (2003). 
Figure 3.6: The function of P-gp in MDR. The hydrolysis of the bound ATP molecule activates 
the efflux pump to drive the cytotoxic drug outside the cell. (Reprinted from Thomas and Coley, 
2003). 
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For the last two decades, P-gp inhibition has been studied as a way of reversing 
MDR. As a result, agents such as verapamil and cyclosporin were identified in 
the 1980s (reviewed in Krishna and Mayer, 2000). These affect the function of P- 
gp as a transporter, hence the name 'modulators' or 'chemosensitisers'. These 
agents have produced some disappointing results when used at clinically 
relevant doses in human subjects. Many of the first generation modulators 
identified were substrates for P-gp and were competitors with the anticancer 
agents for efflux by P-gp. Thus, high serum concentrations were required to 
produce adequate intracellular concentration to exert the desired modulatory 
effect, based on in vitro studies. In addition, many of those agents were not only 
substrates for P-gp, but to other transporter and enzyme systems, resulting in 
unpredictable pharmacokinetic interactions in the presence of anticancer drugs 
(reviewed in Krishna and Mayer, 2000). To overcome these limitations, several 
analogues of these early modulators were developed with the aim of having less 
toxicity and more potency. These were classed as second-generation MDR 
modulators and further developed into the third-generation modulators that are 
being studied in current clinical trials. An example of the former is valspodar 
(PSC833), a non-immunosuppressive derivative of cyclosporin D, which inhibits 
P-gp and with 10-20 fold greater activity than cyclosporin A (Teboekhorst et al. 
1992; Twentyman and Bleehen, 1991). This second- generation modulator is 
also a substrate for cytochrome P450 isoenzyme 3A4. As a result of this, 
competition took place (Figure 3.7) between the anticancer agent and modulator 
for phase I metabolic reactions. Hence, clinical trials highlighted the 
consequential unpredictable pharmacokinetic interactions produced. When 
PSC833 is used with paclitaxel (Taxol), it inhibits the cytochrome P450 3A4 
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mediated metabolism of Taxol causing an increase in serum concentrations, thus 
putting patients at risk of over-exposure (Bates et al. 2001; Fischer et al. 1998). 
Figure 3.7: First and second generation modulators undergo competitive inhibition. The 
modulators compete as substrates with the cytotoxic agents for transport by the pump. This 
would limit the efflux of the cytotoxic agent, increasing its intracellular accumulation. (Reprinted 
from Thomas and Coley, 2003). 
In order to counteract this, the common response by clinical researchers is to 
reduce the dose of the anticancer agent. However, this may still result in under- 
or over-dosing, as the pharmacokinetic interactions between the second- 
generation modulators and anticancer drugs are unpredictable and cannot be 
determined in advance (Gottesman et al. 2002; Fischer et al. 1998). The non- 
specificity of these second- generation modulators to P-gp, such as that of 
PSC833 affecting MRP1 (Krishna and Mayer, 2000; Yanagisawa et al; 1999; 
Rowinsky et al. 1998) may cause adverse effects of anticancer drugs. For 
example, BCRP (breast cancer resistant protein, another example of an ABC 
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transporter) is a functional regulator of the haernopoetic stem cells, and inhibition 
of it may contribute to neutropaenia (Dantzig et al, 1999). 
Generally, the unpredictability of these second generation P-gp modulators on 
cytochrome P450 3A4-mediated drug metabolism has made it difficult to 
establish a safe but effective dose of the anticancer drug. Hence, this represents 
a major limitation in the use of second-generation modulators in treatment of 
MDR. In addition to inhibiting P-gp, second-generation modulators can act as 
substrates for other transporters within the ABC family. Inhibition of these can 
leave other normal cells and tissues less capable of protecting themselves 
against cytotoxic agents, especially when many of these transporters have 
important roles in eliminating xenobiotics such as those in the kidney, liver and 
gastrointestinal tract (Krishna and Mayer, 2000; Thomas and Coley, 2003). 
ABC transporters are also involved in the regulation of the permeability of the 
central nervous system (blood-brain barrier), testes and placenta, thus protecting 
these systems from being exposed to the cytotoxic agents circulating in the 
blood. First- and second-generation modulators act by competitive inhibition of 
P-gp; as a result, the modulator and the anticancer drug would compete for 
transport by the P-gp pump, which in turn limits the efflux of the drug and thus 
causes an increase in its intracellular accumulation. To overcome the limitations 
of the second-generation modulators, third-generation modulators were 
developed to specifically inhibit P-gp potently. These were developed by 
studying the structure-activity relationships, and act by non-competitive inhibition 
of the P-gp pump (Figure 3.8). Some of these may bind with high affinity to the 
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pump but are not substrates themselves (e. g. tariquidar, or also known as 
XR9576). The binding then causes a conformational change in the protein and 
prevents ATP hydrolysis, which inhibits the transport of the anticancer drug 
outside the cell. This results in an increase in the intracellular level of the drug 
(Thomas and Coley, 2003). 
Figure 3.8: Non-Gompetitive inhibition of P-gp. Third generation modulators, such XR9576 
operate in this manner, as it binds to the pump with high affinity, but it is not a substrate. The 
binding causes a conformational change in the protein, hence preventing ATP hydrolysis and the 
transport of the cytotoxic agent to the outside. The drug would therefore accumulate inside the 
cell. (Repdnted from Thomas and Coley, 2003). 
Furthermore, these agents do not affect cytochrome P450 3A4 and have not 
been tested for other ABC transporters, but their specificity to the P-gp pump 
minimises the possibility. An example of a third generation modulator that is 
currently in clinical development is an anthrylamide derivative, called tarquidar 
(XR9576), which is P-gp specific (Roe et al, 1999), but has recently been shown 
to affect another type of the ABC transporter called breast cancer resistant 
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protein (BCRP) (Robey et al, 2004). The inhibitory effect of XR9576 on P-gp 
exceeds those of first- and second- generation modulators with respect to 
potency and duration of action. In an in vitro study, P-gp transport remained 
blocked for more than 22 hours after XR9576 had been removed from the culture 
medium (Mistry et al, 2001). XR9576 specifically and non-competitively binds to 
the P-gp pump with an affinity that greatly exceeds that of the substrates (Van 
Zuylen. et al, 2000). It is not clear whether the binding of XR9576 on P-gp is to 
the ATP binding site, but it inhibits ATPase activity of P-gp. It has been proposed 
that there are multiple drug interaction sites on P-gp that are functionally 
classified as transport. The multiple-binding sites model suggest that XR9576 
binding can prevent substrate binding, alter ATP hydrolytic ability pf P-gp or a 
combination of these two possibilities (Martin et al, 1999). Pharmacokinetic 
studies in healthy subjects show that single doses of XR9576 up to 2 mg/kg 
taken intravenously, or 750 mg orally, are well tolerated and provide complete P- 
gp inhibition for at least 24 hours, according to a study using rhodamine 123 
accumulation in CD56+ lymphocytes (Stewart et al, 2000). XR9576 showed no 
effect on the pharmacokinetics of Taxol or doxorubicin when it was administered 
to patients with solid tumours; (Thomas and Coley, 2003; Abraham et al, 2001; 
Thomas et al, 2001; Ferry et al, 2001). XR9576 is currently in phase III clinical 
trials. 
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Many studies have shown that MDR can be reversed after the use of substrate 
analogues or MDR modulators. However, our understanding of MDR modulation 
is incomplete. A previous study (Vayuvegula et al, 1988) used the membrane 
potential sensitive dye DIOC5 to compare the membrane potential of drug 
sensitive and MDR cancer cell lines before and after treatment with the 
modulators verapamil and cyclosporin A (CsA). The MDR cell lines (the murine 
P388 leukaemia-Adriamycin resistant and human acute lymphatic leukaemia- 
vincristine resistant) were reported to have a lower membrane potential 
compared with their corresponding drug sensitive parental cell lines. Incubation 
of the MDR cell lines with CsA or verapamil appeared to indicate the restoration 
of membrane potentials to that of the parent cell lines. They suggested that 
alteration of membrane potentials was one of the mechanisms responsible for 
MDR in malignancy and showed that it was corrected after using modulators. 
The aim of this chapter is to investigate the dielectric differences between drug 
sensitive and resistant cancer cells, and to relate these to the mechanisms by 
which resistance is conferred to these cells relative to their parent lines. 
Furthermore, DEP has also been employed to elucidate the mechanism of 
action, by means of examining the differences in dielectric properties, which in 
turn can reflect membrane potentials between drug sensitive and MDR cancer 
cells before and after treatment with the modulator XR9576. Our results have 
shown marked differences between the drug resistant and their sensitive 
parental lines, with significant changes in the cytoplasm of these cells. Also, the 
results have cast doubt on the earlier observation by Vayuvegula et al (1988) 
and instead support a later study (Gollapudi and Gupta, 1992) in suggesting that 
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DIOC5 is a substrate for the ABC transporter. The results showed that the 
process of MDR modulation is not associated with changes in the electrical 
properties of cancer cells. Moreover, the results demonstrate that using the flow 
cytometric method alone may produce artefactual results with MDR cells. in 
combination with dielectrophoresis, the results show the role of MDR modulators 
in preventing drug efflux in MDR cells, indicating that using flow cytometry to 
reveal membrane potential is flawed. 
3.2. Materials and methods 
3.2.1. Chemicals and reagents 
Taxol was obtained as a pharmacy preparation (Bristol Myers Squibb, 
Nottingham, UK) and further dissolved in 0.9% NaCl solution to give a 1mM 
stock solution and sterilized by filtering through a 0.2 micron filtration membrane. 
Doxorubicin (Sigma Aldrich, Poole, UK) and XR9576 (was kindly provided by 
Xenova Ltd, Slough, UK), both were dissolved in dimethyl sulfoxide (DMSO) 
(Roe et al, 1999), and stored frozen as stock solutions, which were thawed prior 
to use. 
3.2.2. Cell culture 
Human chronic myelogenous leukaemia (K562), its doxorubicin (formerly known 
as Adriamycin) resistant counterpart (K562AR), human promyelocytic leukaemia 
(HL60) and its doxorubicin resistant counterpart (HL60AR) were grown in 20 mM 
HEPES modified RPMI-1640 medium supplemented with 10% heat-inactivated 
foetal calf serum (FCS), (Invitrogen, Paisley, UK), 2 mM L- glutamine and 100 
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units/ mL penicillin-streptomycin. All cell culture reagents were obtained from 
Sigma Aldrich (Poole, UK), unless stated otherwise. The cells were grown under 
standard cell culture conditions at 370C. K562AR and HL60AR resistance were 
maintained in the presence of 1OOnM and 50nM doxorubicin, respectively. The 
human breast cancer (MCF-7) parent cell line, its Taxol and doxorubicin resistant 
counterparts (MCF-7TaxR and MCF-7DoxR, respectively) were grown in similar 
conditions as that of K562, K562AR, HL60 and HL60AR, using 20 mm HEPES 
modified Dulbecco's Modified Eagle Medium (DMEM) medium (Sigma, Poole, 
UK), with supplements as before. MCF- 7TaxR was maintained in the presence 
of 6 nM Taxol, and MCF-7DoxR was maintained in the presence of 100 nM 
doxorubicin. The parent cell lines were obtained from The European Collection 
of Cell Culture, Porton Down, Salisbury, UK (ECACC), but MCF-7TaxR and 
MCF-7DoxR cell lines were developed by Dr. Helen Coley at the University of 
Surrey, and hence they were novel in-house models. 
Human ovarian resistant tumour cell line (T8) was kindly provided by Professor 
Jan Schellens from the Netherlands Cancer Institute, Amsterdam, and was 
resistant to topotecan. These cells were used as BCRP overexpressing cells and 
were grown using the same reagents and conditions as that for MCF-7, and the 
resistance was maintained at 950 nM topotecan. 
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3.2.3. Confirmation of MDR phenotype 
3.2.3.1. Chemosensitivity testing 
The colorimetric assay using MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5- 
diphenyltetrazolium bromide) was used to titrate cell viability following drug 
treatment, as described by Mosmann (1983). Briefly, K562 and K562AR were 
measured at a density of 1x 105 cells/mL in 20mM HEPES-modified in RPMI- 
1640. Densities of the order 104 cells/mL were used for MCF-7, MCF-7TaxR and 
MCF-7DoxR, as they exhibit a higher exponential growth, and were measured in 
DMEM. The media contained 10% FCS and 100 units/mL penicillin- 
streptomycin. Cells were then dispensed into 96-well plates in volumes of 200 pL 
and left to equilibrate for 24 hours at 370C and 5%CO2. Freshly thawed drug 
solution (doxorubicin or Taxol, depending on the cell line) was diluted in 20mM 
HEPES-modified RPMI-1640 (or DMEM, depending on the cell line) containing 
10%FCS and added in a volume of 50 ýtl- in increasing concentrations. Control 
wells containing cell suspension were supplemented with a similar volume of 
culture medium only. Following 72-hour incubation, cultured cells were treated 
with 20 pl- of 5mg/mL MTT in PBS (Sigma Aldrich, UK). After four hours of 
incubation, the plates containing the leukaemia lines in suspension were 
centrifuged at 200 xg and the medium was removed, as breast cancer cells are 
adherent. Tetrazolium crystals were dissolved in 200 pL of DMSO. Absorbance 
was read at 540nm using an automated ELISA plate reader. The same 
procedure was followed using doxorubicin in the case of MCF-7 and MCF- 
7DoxR, and Taxol in the case of MCF-7 and MCF-7TaxR. The chemosensitiser 
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XR9576 (Xenova Ltd, Slough, UK. ) was added at a 100 nM final concentration 
(Martin et al, 1999) to half of the wells on each plate, so as to ensure that cells 
were exposed to both the drug and the chemosensitiser, while cells in the 
second half were exposed to the drug alone. The results were expressed as IC50, 
i. e. the concentration of cytotoxic drug that reduces cell viability by 50% relative 
to the control (untreated cells). 
3.2.3.2. Western Immuno-blotting 
Crude cell membrane preparations were made using hypotonic lysis buffer 
containing 1 mM PMSF (phenylmethylsulfonyl fluoride, a protease inhibitor), 1 mM 
NaV04, apoprotinin and leupeptin, 150 mM NaCl, in 10 mM Tris buffer (pH 7.4) 
(Helena Biosciences, Sunderland, UK). The cells were left to lyse for 30 
minutes, sonicated and then centrifuged for 10 minutes at 450 xg, followed by a 
further centrifugation (Centrikon-T2060) of 60,000 xg at 40C. The final pellet was 
resuspended in lysis buffer containing 0.2% SDS. The protein content of the 
lysates was determined using a modified Bradford protein assay (Bio-Rad 
Laboratories, Hemel Hempstead, UK). 
50 jig of membrane protein was loaded onto a 10% acrylamide SIDS and 
resolved by SDS-PAGE. The presence of P-gp was detected with anti-P-gp 
rabbit polyclonal antibody, H241. In order to assess the presence of BCRP, the 
mouse BCRP monoclonal antibody was used (both antibodies were purchased 
from Santa Cruz Biotechnology Inc, Autogen Bioclear, Wiltshire, UK). 
Visualisation was carried out using HRP conjugated secondary antibody with 
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chemi luminescence (Pierce, Perbio Science UK Ltd, Cheshire, UK). The 
expression of P-gp was demonstrated by visualising a band of 170kDa in 
molecular weight, and a band of 70kDa for BCRP. 
3.2.4. Cell preparation 
3.2.4.1. DEP experiments 
The drug resistant and sensitive cells were centrifuged at room temperature at 
190 xg for 5 minutes. The pellets were washed and resuspended in isotonic 
medium consisting of 8.5% (w/v) sucrose plus 0.3% (w/v) dextrose buffer 
(Gascoyne et al. 1997). The medium conductivity was adjusted to 2.5 mS/m 
using PBS and the final conductivity, before use, was verified with a conductivity 
meter (IRS components Ltd, London, UK). The final cell population was counted 
using a haemocytometer and adjusted to approximately WO 5 cells/ mL (±15%) 
for DEP measurements. In order to reduce the effect of variation in cell number 
in each sample, the experiments were repeated many times (generally 4-6) with 
different populations, which were summed prior to modelling. 
The same procedure as that mentioned above was followed for K562, K562AR, 
MCF-7 and MCF-7TaxR, only now the XR9576 modulator was used. Drug 
resistant (K562AR and MCF-7TaxR) and their parental cell lines, before and 
after incubation in lOOnM XR9576 for 30 minutes at 37 OC with XR9576), were 
centrifuged at room temperature at 190 xg for 5 minutes. As before, the pellets 
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were washed and resuspended in isotonic medium consisting of 8.5% (w/v) 
sucrose plus 0.3% (w/v) dextrose buffer (Gascoyne et al. 1997). The medium 
conductivity was adjusted to 2.5 mS/m using PBS and the final conductivity) 
before use, was verified with a conductivity meter (RS components Ltd, London, 
UK). The final cell population was counted using a haemocytometer and 
adjusted to approximately 3x1 05 cells/ ml (±15%) for DEP measurements. 
As shown in Figure 3.9, the DEP system consisted of a signal generator, a light 
microscope and the dielectrophoresis chamber in which the cell suspension was 
placed. The dielectrophoretic forces were generated by two needle-shaped 
electrodes, pointing towards each other, with opposing tips spaced 
approximately 100 ýtm apart in a glass petri dish. The needles were formed by 
cutting a thin stainless steel rod at a shallow angle, such that cell collection 
occurred along the sharpened edge. These edges were placed face-down on 
the bottom of the chamber to ensure that cell collection always occurred within 
the field of focus of the microscope. The cell suspension was added to the 
electrodes by micropipette. 
The electrodes were energised by a Thurlby Thandar (Huntingdon, UK) signal 
generator in the range 10 kHz to 20 MHz at an applied voltage of 20 V (peak- 
peak). Recordings were taken by exciting the electrodes for 1 minute and 
counting the collected cells using a hand held tally counter, as described by Pohl 
(1978). The cell density was sufficiently low for the cell population to be disperse 
enough for cell-cell interactions (pearl-chaining) not to significantly affect the 
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results. Similarly, the cells were counted at arrival to the electrode edge to 
ensure accuracy. 
Signal 
generator 
TV screen 
Figure 3.9 :A schematic diagram of DEP arrangement. 
The inter-electrode gaps was chosen to be sufficiently large, and the time over 
which the experiment was performed ensured that the volume over which cells 
were attracted to the electrodes was sufficiently large for variations in the local 
electric field gradient due to cell collection to have a minimal effect on the 
behaviour of the cell collection process. Measurements were taken at five 
frequencies per decade, between 1 kHz and 20 MHz. Experiments were 
observed using a Zeiss inverted microscope and CCD camera. The dielectric 
parameters for each cell line, and in the absence or presence of XR9576 were 
obtained by fitting the measurement spectra to the single shell model (Irimajiri et 
al, 1979). 
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3.2.4.2. Flow cytometry 
K562, K562AR, MCF-7 and MCF-7TaxR cell suspensions were resuspended in 
fresh 20 mM HEPES-modified RPMI-1640, or DMEM, containing 10% FCS (all 
from Sigma, Aldrich, UK) to obtain a cell density in the region of 106/ mL. The 
chemosensitiser XR9576 was used at a final concentration of 100 nM, as for 
chemosensitivity testing. The membrane potential sensitive dye DIOC5 (3,3f- 
Dipentyloxacarbocyanine iodide, obtained from Sigma, Aldrich, UK) was 
prepared, as a stock, in phosphate- buffered saline (PBS) and added to the cell 
suspensions at a final concentration of 10 ýLM. The dye was substituted with 
media in control samples (with and without XR9576). After incubating at 370C for 
30 minutes (with and without XR9576), membrane potentials were recorded 
using a FACS analyser (Becton Dickinson, Oxford, UK). Resting membrane 
potentials from drug sensitive cells were set on the fluorescence scale by 
adjusting the laser using the FL 1-PMT (525 nm) green fluorescence setting on 
the analyser. The cells were gated on volume versus scatter for uniform size 
distribution. The membrane potentials were compared according to the intensity 
of green fluorescence emitted (assigned by the parameter of geometric mean, 
GM, values). Thus, an increased membrane potential (hyperpolarisation) is 
indicated by a higher fluorescence intensity (i. e. a higher GM value), with the 
reverse (hypopolarisation) being seen for lower membrane potentials. 
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3.3. Results 
3.3.1. MDR confirmation using MTT chemosensitivity testing 
Tables 3.1 and 3.2 show the IC50 values (the concentration of the drug that 
reduces the number of cells by 50% relative to control, untreated cells) for 
doxorubicin and taxol, respectively. As illustrated in Table 3.1, the IC5o value for 
K562 and K562AR were 0.58 ýM (± 0.28) and 8.13 ýM (± 1.18) respectively, 
indicating an increase in resistance of 14-fold. The values also show no 
significant inter-assay variation, as the standard deviation values, for each IC50, 
were relatively low. MCF-7DoxR was shown (Table 3.1) to be resistant to 
doxorubicin, relative to the parental cell line, MCF-7, as it showed 5-fold 
resistance. Table 3.2 shows the IC50 values obtained for MCF-7 and MCF- 
7TaxR after treating with Taxol. The resistance phenotype was evident in MCF- 
7TaxR relative to the parent MCF-7, as the resistance fold was 15 (Table 3-2). 
Table 3.1: The doxorubicin IC50 values for the doxorubicin sensitive and resistant cell lines (n=4) 
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Table 3.2 The Taxol IC50 values of the Taxol sensitive and resistant cell lines (n=4) 
3.3.2. MDR confirmation using Western immunoblotting 
3.3.2.1 P-gp expression 
In addition to the MTT assay discussed earlier, the Western immunoblot (Figure 
3.10) visualisation has revealed the expression of the MDR protein, P-gp. The 
blot showed the expression of P-gp in the MDR cell line (K562AR), but was 
absent in the parental (K562) cells. The same blot shows a more intense band, 
indicating a greater degree of expression of P-gp, in the resistant breast cancer 
cell line (MCF-7TaxR). On the other hand, MCF-7D0xR showed no expression of 
P-gp. The human myeloid leukaemic cell lines (HI-60) and its doxorubicin 
counterpart (HL60AR) were used as negative controls for P-gp, as HL60AR 
expresses another MDR protein known as the multidrug resistance associated 
protein (MRP) of 190 kDa in molecular weight. 
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Figure 3.10: A Western blot showing the expression of P-gp in different cell lines. The expression 
of the protein is indicated by the arrow pointing to its molecular weight (1 70kDa) 
3.3.2.2. Breast cancer resistant protein (BCRP) expression 
MCF-7DoxR lacked the expression of P-gp, but was found to be positive in 
expressing another ABC transporter protein, known as breast cancer resistant 
protein, BCRP (Figure 3.11). The same band intensity was seen in both MCF-7 
and MCF-7DoxR, indicating the same level of BCRP expression in both cell 
lines. T8 was used as a positive control that overexpresses BCRP. 
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Figure 3.11: A Western blot showing the expression of BCRP in different cell lines. Positive 
expression was evident by a band shown at 70kDa in molecular weight. T8 was a positive control 
that overexpresses BCRP. 
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3.3.3. MDR modulation 
Table 3.3 shows the IC50values (the concentration of the drug that reduces the 
number of cells by 50% relative to controls) for doxorubicin. As illustrated, the 
IC50value for K562 was 0.6 ýM (± 0.3) and 8.1 ýN (± 1-2) respectively, indicating 
resistance of 14-fold. The treatment of K562AR cells with doxorubicin in 
combination with the modulator XR9576 reduced the IC50value to resemble that 
of the parent cell line (0.5 ýM ±0.1 and 0.6 pM ±0.3, respectively), indicative of 
resistance reversal. 
Table 3.3: MTT results of Doxorubicin and XR9576 (1 OOnM) for K562 and K562AR surnmarising 
the IC50values after 72 hours incubation and of at least three experiments. 
The IC50 for MCF-7 relative to MCF-7TaxR can be seen in Table 3.4, where the 
resistance fold was 15, thus confirming the resistance phenotype of MCF-7TaxR- 
XR9576 modulation reversed the resistance, as demonstrated by the drop in IC5o 
following treatment. 
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Table 3.4: MTT results of Doxorubicin and XR9576 (1OOnM) for MCF-7 and MCF-TaxR, 
summarising the IC50 values after 72 hours incubation and of at least three experiments. 
3.3.4. DEP experiments 
3.3.4.1. Drug sensitive versus drug resistant cancer cells 
The data points are the average of at least 5 experiments. For each experiment, 
the number of cells collected was noted after applying an electric field for 1 
minute exposure to each frequency, using a range of frequencies between 5 
kHz-20MHz, at 5 frequencies per decade. Parameters such as conductivity and 
permittivity of both membrane (represented as specific membrane capacitance) 
and the cytoplasm were obtained using the Classius-Mossotti equation based 
modelling, where the dielectric parameters were estimated using a single shell 
dielectric model (Huang et al. 1992). From Table 3.5 and Figure 3.12, it can be 
seen that K562 and K562AR began collecting above 104 Hz in frequency. 
3.32 
mwr-ýý I ýý PF1: 1 - 
However, the collection rate showed a decline above 2-3 MHz for K562, unlike 
K562AR where the decline began at 8-10MHz. 
CY (S/M) 
K562 0.23 
(0.21- 0.24) 
K562AR 0.50 
(0.48- 0.51) 
6 K, (n S) C, 
pec 
(mF/M2) 
40-80 0.008 3.9 
(3.3-3.6) 
40-80 0.008 3.5 
(2.9-4.1) 
Table 3.5: DEP parameters for K562 and K562AR (radius= 4.3 ýLrn for both cell lines) 
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Figure 3.12: DEP best fit models for K562 (A) and K562AR (B) 
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Table 3.5 shows the parameters calculated for the cytoplasm and membrane. 
The calculation was based on obtaining the best fit to experimental data. The 
best fit was found by scaling the polarisability by an arbitrary factor to match the 
curve to the measured data, and then altering the permittivity and conductivity of 
the membrane and cytoplasm until a best match was found. K562 had a 
significantly lower cytoplasmic conductivity than K562AR (0.23 and 0.50 S/m, 
respectively), indicating a lower ionic strength, in the drug sensitive K562 in 
comparison to the resistant counterpart, K562AR. Also, there were no significant 
changes in the membrane morphology as the specific membrane capacitance 
values were not significantly different in the two cell lines. The numbers in 
brackets, in the table indicate the ranges, between which, the curve would still 
best fit the data. Outside those ranges, the curves would no longer best fit the 
data. The same procedure was used to obtain similar measurements for MCF-7, 
MCF-TaxR (Table 3.6 and Figure 3.13) and MCF-7DoxR (Table 3.7 and Figure 
3.14). 
CY (S/M) 6 Ks (n S) Cspec (MF/M2) 
MCF-7 0.23 40-80 0.010 6.0 
(0.22- 0.24) (5.5-6.6) 
MCF- 0.14 40-80 0.010 8.3 
7TaxR (0.13- 0.15) (8.2-8.9) 
Table 3.6: DEP parameters for MCF-7 (radius= 9.3 ýLrn) and MCF-7TaxR (radius= 9.6 ýLrn) 
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Figure 3.13: DEP best fit models for MCF-7 (A) and MCF-7TaxR (B) 
From Figure 3.13, the collection of MCF-7 started around 1OkHZ, while that of 
MCF-7TaxR started around 5kHZ. The collection of MCF-7 decreased above 
6MHz, while that of MCF-TaxR decreased around 250kHZ. The parameters 
obtained from these fits are summarised in Table 3.6. MCF-7 had a higher 
cytoplasmic conductivity relative to its MDR counterpart, MCF-7TaxR (0.23 and 
0.14 S/m, respectively). This implies a lower ionic content in the cytoplasm of the 
drug sensitive breast cancer cell line than that of MCF-7TaxR. Also, the results 
highlighted noticeable differences in the membrane morphology, as the specific 
membrane capacitance increased from 6.0 mF/M2' in MCF-7, to 8.3 mF/M2 in 
MCF-7TaxR. 
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There were no significant changes in the surface conductance (Ks). Also, the 
model was insensitive to cytoplasmic permittivites over a broad range (40-80 F-0. 
From Figure 3.14, the collection of MCF-7DoxR began around lOkHZ and later 
declined above 4MHZ- This best fit then produced the parameters summarised in 
Table 3.7. It can be seen that the cytoplasmic conductivity of MCF-DoxR 
increased to 0.40S/m relative to the parent drug sensitive cell line MCF-7 
(0.23S/m), with a slight increase in the specific membrane capacitance (6.4 
mF/m 
2) 
relative to the parent MCF-7 (6. OmF/M2). 
(Y (S/M) & Ks (n S) cspec (MF/M2) 
MCF-7 0.23 40-80 0.011 6.0 
(0.22-0.24) (5.5-6.6) 
MCF- 0.40 40-80 0.01 6.4 
DoxR (0.38-0.41) (5.8-7.1) 
Table 3.7: DEP parameters for MCF-7 (radius= 9.3 ýLrn) and MCF-7DoxR (radius= 9.6 ýtm) 
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Figure 3.14: DEP best fit models for MCF-7 (A) and MCF-7DoxR (B) 
3.3.4.2. MDR modulation 
The results of modelling are summarised in Table 3.8 for K562 and K562AR, 
before and after modulation with XR9576, and Table 3.9 for MCF-7 and MCF- 
TaxR, before and after modulation. K562 had a lower cytoplasmic conductivity 
relative to K562AR (0.23 and 0.50 S/m, respectively), while MCF-7 had a higher 
cytoplasmic conductivity relative to its MDR counterpart, MCF-7TaxR (0.23 and 
0.14 S/m, respectively). Comparison of the membrane specific capacitance of 
MCF-7TaxR relative to MCF-7 reveals that the former is greater significantly (8.3 
and 6. OmF/M2 , respectively). 
Overall, the breast cancer cell lines exhibited 
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differences in their membrane properties by displaying a higher membrane 
specific capacitance relative to the leukaemic cell lines. Following treatment with 
XR9576, none of the dielectric parameters were seen to vary by more than 15% 
in K562, K562AR and MCF-7, but around 25% increase In the specific 
membrane capacitance was seen after XR9576 modulation in MCF-7Ta-xR (8.3 
and 10.5mF/M2 , respectively). 
Cytopl asm ei nb ra ne 
a (S/M) Ks (n S) Cspec (MF/M2 
K562 0.23 40-80 0.008 3.9 
(0.21- 0.24) (3.3-3.6) 
K562AR 0.50 40-80 0.008 3.5 
(0.48- 0.51) (2.9-4.1) 
K562+ 0.20 40-80 0.008 3.9 
XR9576 (0.19- 0.21) (3.3-3.6) 
K562AR 0.55 40-80 0.008 3.5 
+ (0.51- 0.58) (2.9-4.1) 
XR9576 
Table 3.8: A summary of the DEP results showing the electrical parameters of both the 
cytoplasm and the membrane of K562 (radius= 4.3 ýLm) and K562AR (radius= 4.3 ýLm) before 
and after modulation with XR9576 (cy=ý Conductivity, F, =. permittivity, Ks = surface conductance, 
Cspec= specific capacitance) 
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I 
Cytopl asm Mem brane 
CY (S/M) Ks (n S) Cspec (nF/M2) 
MCF-7 0.23 40-80 0.010 6.0 
(0.22- 0.24) (5.5-6.6) 
MCF- 0.14 40-80 0.010 8.3 
7TaxR (0.13- 0.15) (8.2-8.9) 
MCF-7+ 0.26 40-80 0.011 6.0 
XR9576 (0.25- 0.27) (5.5-6.6) 
MCF- 0.14 40-80 0.010 10.5 
7TaxR+ (0.13- 0.15) (9.9-11.1) XR9576 
Table 3.9: A summary of the DEP results showing the electrical parameters of both the 
cytoplasm and the membrane of MCF-7 (radius= 9.3 ýLrn) and MCF-7TaxR (radius= 9.6 ýLrn) 
before and after modulation with XR9576 (cy=. Conductivity, 6=. permittivity, Ks = surface 
conductance, Cspec = specific capacitance) 
3.3.5. Flow cytometry 
Membrane potentials of drug sensitive and resistant cancer cells were assessed 
after 30 minutes exposure to the dye. The results for K562, K562AR, MCF-7 and 
MCF7TaxR before and after modulation are shown in Figures 3.15 and 3.16, 
respectively. These are representatives of many experiments and they all have 
shown similar patterns. Control drug sensitive and resistant cancer cells before 
and after treatment exhibited negligible fluorescence before using DIOC5. The 
green fluorescence intensity emitted by the dye, as shown in Figure 3.15, was 
markedly decreased in K562AR (GM value = 36) relative to the K562 parental 
cell line (GM value = 124). 
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Flow cytometry results of K562 and K562+ XR9576 
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Figure 3.15: Flow cytometry data for K562 and K562AR before and after modulation with 
XR9576 
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Fluorescence 1 
(Green fluorescence using DIOCS) 
Flow cytometry results of K562AR and K562AR+ XR9576 
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R"escence 1 
(Green fluorescence using DIOC5) 
The modulator XR9576 did not have a significant effect on the green 
fluorescence intensity in K562, with GM values unchanged following treatment 
with XR9576 (126). However, the use of XR9576 with K562AR had a striking 
effect on the fluorescence intensity giving GM values of 491 relative to 124 for 
the parent K562 cell line. Similar effects were observed in MCF7 and 
MCF7TaxR (Figure 3.16), where the resistant cell line prior to treatment, MCF- 
7TaxR had a lower fluorescence (GM=84) relative to the parent MCF-7 (243). 
After treatment, the modulator did not have a significant effect on the 
fluorescence intensity of the parental line (GM values 243 and 272 before and 
after treatment, respectively), whereas the intensity for MCF-7TaxR increased 
markedly (GM= 162) after treatment relative to (GM= 84, before treatment). 
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Flow Cytometry results of MCF-7 and MCF-7+ XR9576 
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Figure 3.16: Flow cytometry data for MCF-7 and MCF-7TaxR before and after modulation with 
XR9576 
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3.4. Discussion 
3.4.1. Comparison of drug sensitive and resistant cells 
The MDR status in K562AR was confirmed by the MTT results in Table 3.1, 
which demonstrated that the cells showed a 14 fold resistance to doxorubicin 
relative to the parent K562 cells. Figure 3.10 also indicated that K562AR 
expressed P-gp, which was absent in the parent K562. Furthermore, the MTT 
results in Table 3.3 demonstrated MDR reversal after using the P-gp specific 
modulator XR9576. These results point to P-gp being the sole contributor to 
MDR in K562AR. The DEP data from Table 3.5 and Figure 3.12 showed that 
there was no discernable difference in the specific membrane capacitance of 
K562 and its MDR counterpart, K562AR (3.9 and 3.5 mF/M2 , respectively), 
indicating no significant difference in the membrane morphology. Similarly, no 
significant difference was seen in the surface conductance between the two cell 
lines. However, Table 3.5 and Figure 3.11 highlighted a difference in the 
cyoplasmic conductivity. K562 had a lower cytoplasmic conductivity relative to its 
MDR counterpart, K562AR (0.23 and 0.50 S/m, respectively), indicating a higher 
ionic content in the cytoplasm of the resistant cell. 
The increase in the cytoplasmic ionic content in K562AR may be attributed to a 
number of possible mechanisms, most of which involve the increased expression 
of activity of certain ion channels or pumps, contributing to an increase in the 
quantity of ions present in the cytoplasm of K562AR cells relative to those in the 
parent K562. The expression of P-gp itself may be one mechanism for this 
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increase in cytoplasmic conductivity. P-gp has variously been reported to be a 
Cl' channel (Valverde et al, 1992; Altenberg et al, 1994 and reviewed by 
Wadkins and Roepe, 1997) or bifunctional with one function as a Cl- channel and 
another as a pepticle transporter (Gill et al, 1992; Zhang and Ling, 1995). It has 
also been noted that P-gp shares homology with the cystic fibrosis 
transmembrane conductance regulator (CFTR) (Welsh et al, 1992 and as 
reviewed by Gadsby and Nairn, 1999), a known Cl- channel, and also with 
sulphonyl-urea regulator (SUR). CFTR and SUR proteins have also been 
implicated with the regulation of other ions in the cytoplasm, including Na+ and 
Ca 2+ , respectively, as reviewed by Wadkins and Roepe (1997). Belhoussine et al 
(1999) showed that the vesicular pH was more acidic in K562AR cells (pH=5.90) 
relative to the parent (pH=6.02), while the cytoplasmic pH was more alkaline in 
K562AR relative to K562 (pH= 7.06 and 6.94, respectively). The lower pH seen 
in sensitive cells (K562) was suggested to correlate with disruption in the trans- 
Golgi network (TGN). The organisation of TGN appeared more compact in MDR 
cells (Simon and Schindler, 1994; Altenberg et, 1993; Schindler et al, 1996; Altan 
et al, 1998) including K562AR (Belhoussine et al, 1999). Belhoussine et al 
(1999) noted that drug sensitive cells had a lower number of acidified vesicles, 
suggesting a diminished capacity of cells to remove protonated drugs from the 
cytoplasm to secretory compartments followed by their secretion through the 
activity of the recycling pathways. The same pattern of acidified vesicular pH and 
alkaline cytoplasmic pH was observed in the doxorubicin resistant breast cancer 
cell line, as discussed later in this section. 
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In MCF-7 and MCF-7TaxR (Table 3.6 and Figure 3.12), there was no significant 
difference in the membrane parameters between the two cell lines. However, a 
significant difference in the cytoplasmic conductivity was observed, where MCF- 
7TaxR had a much lower conductivity relative to the parent (0.14 and 0.23 S/m, 
respectively). This indicates that MCF-7taxR has a lower ionic content relative to 
the parent MCF-7. This change is surprising when compared with K562AR, as 
both cell lines overexpress P-gp. The mechanism by which MCF-7TaxR loses its 
conductivity is uncertain, but a number of suggestions can be made. P-gp has 
also been described as a regulator of other channels, e. g. Cl- channels in the 
membrane (Gill et al, 1992; Valverde et al, 1992; Hardy et al, 1995). A regulator 
may not necessarily mean an activator of the Cl- channel, as it could similarly de- 
activate it, this may cause a reduction in the inflow of Cl- into the cytoplasm, 
thereby reducing the ionic content. 
The results mentioned earlier highlight the possibility of different mechanisms 
taking place to account for the different patterns seen in the data. In the case of 
the MDR cell lines K562AR and MCF-7TaxR, both cell lines showed an 
overexpression of P-gp relative to their parental lines. Furthermore, MTT results 
showed similar (at least 14 and 15 fold) increases in resistance were obtained for 
K562AR and MCF-7TaxR. Also, for both lines, resistance was reversed by the 
use of the P-gp specific modulator XR9576 indicating that P-gp was the sole 
source of resistance. However, the cell lines exhibited opposite cytoplasmic 
conductivity shifts relative to their parental cells. The cytoplasmic conductivity 
was higher in K562AR relative to the parent. One mechanism that could be 
proposed for K562AR, relative to K562, is that P-gp is acting as a Cl- channel. P- 
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gp has been known to act as a drug transporter, which expels anticancer drugs 
to the outside of the cell, as well as being and regulating Cl- channels (as 
reviewed by Wadkins and Roepe, 1997). In acting as a Cl- channel, the Cl- ions 
are permitted to enter the cytoplasm, thus causing an increase in the number of 
ions present and giving the evident high cytoplasmic conductivity seen from the 
DEP data. Other possible contributors to this high cytoplasmic conductivity might 
involve the low level of activity of the Na+/H+ (NHE) and the CIIHC03- anion 
exchanger. A high level of activity of the NHE pump may cause an accumulation 
of Na+ ions in the cytoplasm. 
In the case of MCF-7TaxR, lower cytoplasmic conductivity was obtained despite 
the overexpression of P-gp relative to the parent MCF-7. P-gp has been 
speculated to have different toplogical structures that are modulated by specific 
cytoplasmic factors (Zhang and Ling, 1995); another study (Luker et al, 2001) 
showed P-gp function is not affected by membrane potential in the same cell 
line. It is known that free cytoplasmic Mg2+ is removed by binding to ATIP, RNA 
and by the Na + /Mg 2+ antiport (Wolfe, 1993). It is be possible that the 
overexpression of P-gp (an ATP driven pump) could result in the over- 
expenditure of the free Mg2+, causing a deficit in the cytoplasm and reducing the 
overall ionic content, as it forms the basis of Na +/Mg2+ pump function. 
MCF-7DoxR showed significantly different MTT and Western immunoblotting 
results (Table 3.1, and Figure 3.10, respectively), showing 5 fold resistance and 
lacking the expression of P-gp. It was positive for the expression of BCRP, as 
was the parent MCF-7. The Western blot (Figure 3.11) indicated a similar level of 
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BCRP expression in both MCF-7 and MCF-7DoxR. Despite BCRP being a 
member of the ABC transporter family (formally designated ABCG2) it is not 
usually used as a marker for MDR in the same way as P-gp, and is expressed in 
some drug sensitive breast cancer cell lines. This is confirmed by the presence 
of BCRP in the drug sensitive (parent) MCF-7 (Figure 3.11). Furthermore, 
XR9576 is known to act on BCRP as well as P-gp (Robey et al, 2004), but 
treatment only marginally (17%) reversed resistance in MCF-7DoxR, indicating 
that only BCRP plays a small role in conferring resistance in MCF-7DxoR. 
It has been noted in literature that not only does MDR involve the expression of 
different ABC proteins, but is also associated with drug sequestration and 
compartmental isation inside vesicles and cytoplasmic organelles away from the 
target site (Sognier et al, 1994; Slapak et al, 1992; and reviewed in Dietel, 1991). 
Sognier and co-workers suggested the possibility of the simultaneous existence 
of multiple resistance mechanisms inside the same cell. The group found that the 
drug sequestration phenomenon correlates with the level of drug resistance and 
occurs rapidly following exposure to doxorubicin. 
From the results obtained, it is evident that MCF-DoxR, grown in our study, 
operates a MDR mechanism that is non-P-gp related. It is therefore suggested 
that the MDR mechanism operating in these cells is that of drug sequestration 
and secretion. It has been reported that a MCF-7DoxR cell line has an alkaline 
cytoplasmic pH (Warburg, 1956; Simon and Schindler, 1994), while the vesicular 
pH is more acidic in resistant than sensitive cells. The change in the sensitive 
cells was also correlated with the disruption of the trans-Golgi network (TGN) 
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(Altenberg et al, 1993, Schindler et al, 1996, Altan et al, 1998, Belhoussine et al, 
1999). Schindler et al (1996) explained that sensitive cells exhibited a diminished 
capacity to remove cytotoxic drugs from the cytoplasm by sequestration of 
protonated drugs within the vesicles. The group indicated that protonation, 
sequestration and secretion are the principal elements of the primary mechanism 
for doxorubicin resistance in MCF-7 breast cancer cell line. 
Studies (Warburg, 1956; Simon and Schindler, 1994; Altenberg et, 1993; 
Schindler et al, 1996; Altan et al, 1998; Belhoussine et al, 1999 and reviewed in 
Larsen et al, 2000) have shown that the vesicular pH was more alkaline in the 
drug sensitive breast cancer cells (MCF-7) than the doxorubicin resistant breast 
cancer cells and normal healthy cells from the breast, while the cytoplasmic pH 
was acidic in the sensitive MCF-7. On the other hand, the cytoplasmic pH was 
more alkaline in the doxorubicin resistant cells and the normal breast cells 
relative to the sensitive MCF-7 cells (Figures 3.413 for a normal breast cell, 3.5A 
for the drug sensitive MCF-7 and 3.5B for the MDR doxorubicin resistant breast 
cancer cells). In the sensitive cells, the defect, as described by Larsen (2000) 
and Schindler et al, 1996, was correlated with disruption in the Golgi network and 
was due to a diminished capacity of cells to remove drugs from the cytoplasm. 
Weak base drugs such as doxorubicin (pKa= 8.34, Raghunand and Gillies, 2000) 
may be expected to be protonated in the more acidic cytoplasm of drug sensitive 
cell lines, and sequestered in the more acidic vesicles of drug resistant cell lines 
(Wadkins and Roepe, 1997). The zwitterionic drug paclitaxel (Taxol), on the 
other hand has no ionisable groups (Raghunand and Gillies, 2000 and private 
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communication with Bristol-Myers Squibb, Nottingham, UK) and the cell may 
therefore adopt a different mechanism to resist this drug. 
It has been suggested the some MDR cell lines overexpress a subunit of the 
vacular-type H+ - ATPase (V-type) (Ma and Center, 1992). The plasma 
membrane V-ATPase activity and an increase in the rates of endosomal turnover 
have been reported in the MDR MCF-7 variants (Marti nez-Zagui Ian et al, 1993). 
As with K562AR, NHE overexpression may also play a role. These act to 
regulate the internal pH of the cytoplasm, as H+ ions are either expelled from the 
cell or into vesicles, making cytoplasm more alkaline and the vesicles more 
acidic. Aharonovitz and co-workers suggested that NHE activity is very 
sensitively dependent of the intracellular and extracellular concentrations of Na+ 
and H+. They also found that NHE1 activity is modulated by Cl-, where the 
interaction of the intracellular Cl- and the carboxylic terminus of the NHE1 is 
essential for optimal activity. On the basis of this finding, it is possible that MCF- 
DoxR has a defect in this type of NHE due to the lack of P-gp. The lack of P-gp 
may imply a lower Cl- concentration in cell, in turn causing an accumulation of 
the Na+ ions in the cytoplasm. 
The results collectively indicate the possibility for there being at least two 
mechanisms by which the cytoplasmic conductivity changes between MDR cells 
relative to parent cells. One mechanism is P-gp dependent, whereby the P-gp is 
acting as a Cl- channel causing an influx of Cl- into the cell and raising the 
cytoplasmic conductivity as it is in the case of K562AR relative to the parent. In 
the case of MCF-7TaxR, where P-gp is overexpressed but the cytoplasmic 
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conductivity is lower than the parent, the mechanism may be that P-gp is not 
acting as a Cl- channel all the time, but acts as a Cl- channel or a regulator of Cl- 
channels and SUR (as reviewed in Wadkins and Roepe, 1997), as P-gp function 
is not affected by membrane potential (Luker et al, 2001). Another possibility is 
that of the deficit of Mg2+ ions in the cytoplasm as Mg2+ binds to ATP and the P- 
gp pumping action requires ATP expenditure. A third possibility may involve the 
overexpression of the vacular type H+ -ATPase, which has been reported to be 
overexpressed in MDR breast cell line. This takes part in controlling the 
cytoplasmic pH by reducing the number of H+ ions in the cytoplasm. If this 
ATPase is overexpressed, a reduction of the total cytoplasmic ionic content may 
be possible. 
In the case of MCF-DoxR, cytoplasmic conductivities change is non - P-gp - 
dependent. Schindler et al (1996) indicated that protonation, sequestration and 
secretion are the principal elements of the primary mechanism of doxorubicin 
resistance in MCF-7 breast cancer cells. The same pattern for MCF-7 and MCF- 
7DoxR as well as K562 and K562AR, as well as TGN organisation and how the 
resistant cells showed a more compact and organised TGN, were shown by 
Belhoussine et al (1999). 
A study by Aharonovitz et al (2001) reported Cl- to be critical for the action of 
NHE and the ion modulates the action of NHE1. The lack of P-gp in MCF-7DoxR 
may imply a lower Cl- if any. This defect may cause an accumulation of Na+ in 
the cytoplasm, hence the high cytoplasmic conductivity. 
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Considering both K562AR and MCF-7DoxR together, results may indicate a 
potential defect in the NHE pumps both in K56AR and MCF-DoxR, resulting in 
Na+ accumulation, and in the case of K562AR, the overexpression Of P-9p could 
have the potential of having more Cl- inside the cells, if P-gp is acting as a Cl- 
channel. In MCF-7DoxR, however, the principal drug resistance mechanism is 
that of drug sequestration, lack of Cl- could affect the activity of NHE, as Cl- is 
crucial for NHE activity, so a defect could cause more Na' in the cytoplasm. As 
for MCF-7TaxR, though there is an overexpression of P-gp, it may only behave 
as a Cl- regulator rather than a channel, thereby affecting the influx of Cl- by 
deactivating the other Cl- channels, resulting in a lower total ionic strength inside 
the cell. 
The DEP results have interestingly demonstrated how two different cell lines of 
the same parent drug sensitive cell line can have a dramatically differing 
dielectric properties. This is evident in the cytoplasmic conductivities of MCF- 
7TaxR and MCF-7DoxR (0.14 and 0.40 S/m, respectively) (Tables 3.6,3.71 
respectively), relative to the parent (0.23 S/m). Also, around 30% increase in the 
specific membrane capacitance was seen in MCF-7TaxR relative to MCF-7DoxR 
(8.3 and 6.4 mF/M2) if compared to the slightly lower specific capacitance of the 
parent MCF-7 (6.0 mF/M2), indicating possible membrane morphology 
differences. 
3.51 
3.4.2. Effects of MDR modulation 
Using the membrane potential sensitive dye (DIOC5) K562 had a much higher 
fluorescence emitted, producing a more pronounced shift to the right (Figure 
3.15) in comparison to the K562AR peak (with GM values of 124.04 and 36.42, 
respectively). In the case of the breast cancer cell lines, a similar pattern was 
seen, whereby MCF-7 had a much higher fluorescence than the resistant 
counterpart, MCF-7TaxR (83.87) (Figure 3.16). This, according to the work of 
Vayuvegula et al (1988) indicates a higher membrane potential in the parent 
cells K562 and MCF-7 relative to their resistant counterparts K562AR and MCF- 
7TaxR. The modulator XR9576 did not have an effect on the green fluorescence 
intensity in the parent cells, with GM values remaining more or less the same 
before and after treatment with XR9576. On the other hand, the use of XR9576 
with the MDR cell lines produced a pronounced increase in the fluorescence 
emitted relative to that before treatment. K562AR had a GM of 36.42 and 491.15, 
before and after treatment, respectively (Figure 3.15). A similar, yet less dramatic 
effect was seen in MCF-7TaxR, as it had a GM of 83.87 and 162.44, before and 
after treatment, respectively (Figure 3.16). It can be seen from the DEP data in 
Table 3.5 that the drug sensitive K562 appears to exhibit a lower cytoplasmic 
conductivity (0.23 S/m) than its MDR counterpart K562AR (0.50 S/m), before and 
after treatment with XR9576. This indicates different ionic strengths or content in 
the cytoplasm of the parent cells compared to MDR cells. Conversely, MCF-7 
parental cells exhibited a higher cytoplasmic conductivity (0.23 S/m) relative to 
their MDR counterpart, MCF-TaxR (0.14 S/m). Furthermore, there was a notable 
difference in the trends for the specific membrane capacitance of these breast 
cancer cell lines. Whilst K562 (3.9 mF/M2 ) and K562AR (3.5 mF/M2) displayed 
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no differences in their specific membrane capacitance, MCF-7 had a lower 
specific membrane capacitance of (6.0 mF/M2 ) relative to MCF-7TaxR (8.3 
mF/m 2 ). Specific membrane capacitance is related to membrane permittivity and 
surface area but is independent of membrane thickness, so that changes in 
membrane morphology (e. g. blebbing or foldings which alter surface area) cause 
changes in the specific capacitance. In the case of MCF-7TaxR (Table 3.6), the 
capacitance has increased, indicating differences in the membrane morphology, 
possibly due to more membrane foldings (Wang et al, 2002). 
In spite of the presence of P-gp in both K562AR and MCF-7TaxR, the DEP 
results for K562AR indicate that the electrical properties remained largely the 
same after treatment with XR9576 in both parental K562 and the resistant 
counterpart K562AR. In the case of MCF-7TaxR, the specific membrane 
capacitance increased after XR9576 modulation to 10.5mF/M2, giving more than 
25% increase relative to MCF-7TaxR before treatment (8.3mF/M2) . This possibly 
indicates that XR9576 has caused changes in the membrane morphology such 
as foldings after treatment. 
On the other hand, K562 exhibited a significantly lower cytoplasmic conductivity 
than K562AR (0.23 S/m versus 0.50 S/m, respectively) (Table 3.5) indicating a 
lower cell ionic content, while the reverse was seen for MCF-7 relative to MCF- 
7TaxR (0.23 and 0.14 S/m, respectively) (Table 3.6). Thus, these data have 
discriminated the cell lines according to their different dielectric properties. DEP 
has, therefore, brought attention to differences in the cytoplasm, a part of the cell 
that is not often considered in MDR. 
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By comparing the results obtained from DEP and flow cytometry, it can be seen 
that DEP results clearly do not agree with those obtained by flow cytometry. 
However, examination of these differences can yield useful information. The 
DEP results showed that neither the cytoplasmic nor the membrane parameters 
were altered in the presence of XR9576 for K562AR, but the membrane specific 
capacitance changed and increased for MCF-7TaxR (Table 3.6); in spite of P-gp 
expression. However, flow cytometry data (Figure 3.15), suggested an increase 
in membrane potential following modulator treatment for K562AR and MCF- 
7TaxR. This contradictory result may indicate that without the modulator, the P- 
gp could be pumping DIOC5 dye out of the cell, giving an artefactual result. 
The contradictory results can be resolved if XR9576 is considered to be blocking 
the P-gp pump and thus preventing the efflux of the dye. In this regime, the 
fluorescent dye entering the membrane of the drug-resistant cells was pumped 
out, resulting in an artificially low fluorescence and implied low membrane 
potential. When P-gp is blocked, this pumping action does not occur and the high 
fluorescence level truly reflects the high cytoplasmic ionic strength. This resolves 
the differences between the two results, and also highlights the P-gp blocking 
effect of the XR9576 compound. This mechanism of action is illustrated in Figure 
3.17 overleaf. 
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Figure 3.17: The mechanism proposed for P-gp. (1) A drug sensitive cell, where DIOC5 dye 
permeates the membrane, thus giving a high level of fluorescence (indicative of membrane 
potential) (2) A drug resistant cell prior to XR9576 treatment; DIOC5 permeates the 
membrane, but is then expelled from the cell via P-glycoprotein, thus giving an artefactually 
low level of fluorescence (indicating low membrane potential) (3) A drug resistant cell 
subsequent to XR9576 treatment, hence XR9576 blocks P-glycoprotein and therefore 
prevents DIOC5 from being extruded, thus giving rise to increased cellular fluorescence 
relative to (2)-increased, true membrane potential. 
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When the pump is blocked, we suggest that as the DIOC5 is no longer efluxed, 
flow cytometry gives an accurate reading of the membrane potential. Notably, 
the trends in the ratios of cytoplasmic conductivity for parental and resistant lines 
closely follow the pattern of ratios of the GM values and hence membrane 
potential, indicating that the membrane potentials and cytoplasmic conductivities 
are as one might expect closely related. This finding is in agreement with a 
previous study that suggested DIOC5 as being a substrate for ABC transporters 
(Gollapudi and Gupta, 1992). In the presence of XR9576, the membrane 
potential values were much higher than that seen for those cell lines before 
modulation. These results do not coincide with the DEP data obtained, as there 
was no significant difference in the biophysical properties after treatment. 
3.5. Conclusions 
In this chapter, DEP was used to reveal any dielectric differences in resistant 
MDR chronic myelogenous leukaemia (K562AR) and breast cancer (MCF-7TaxR 
and MCF-7DoxR) cell lines relative to the parent drug sensitive cell lines. The 
results obtained point to significant differences in the cytoplasmic ionic content 
with no significant differences seen in the membrane parameters. However, the 
change in polarisation state differs in the leukaemic cell lines; K562AR is 
hyperpolarised relative to K562, whilst MCF-7TaxR is depolarised and MCF- 
7DoxR hyperpolarised in comparison to the parental line, MCF-7. The results 
suggest that these dielectric changes are due to different cellular processes and/ 
or mechanisms. Two mechanisms have been suggested, one of which is P-gp 
dependent and relies on the pump acting as a Cl- channel, as in K562AR. It is 
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worth noting that the dielectric changes may not be P-gp related. MCF-7TaxR 
showed an evident overexpression of P-gp, but we suggest that it is behaving 
more like a regulator, which could imply a deactivating role in the Cl- channels, 
possibly resulting in a reduction of the total ionic content and the lower 
cytoplasmic conductivity relative to the parent. The third mechanism is non- P-gp 
-dependent, as in MCF-7DoxR, where the principal mechanism of drug 
resistance is that of drug sequestration and vesicular trafficking, the cytoplasmic 
conductivity was higher than the parent. This MDR cell line lacked the 
expression of P-gp, and the potential mechanism of this might involve a defect in 
the Na'/H' ATPase (NHE), resulting in the accumulation of Na+ in the cytoplasm. 
This warrants further research with regards to the presence and activity of the 
channels, such as P-gp, Cl- channels and NHE pumps. 
We have also shown that DEP can be used as a technique to probe any 
biophysical differences between cell lines before and after modulation. XR9576, 
a P-gp specific modulator did not exert any effects on the cytoplasm or 
membrane parameters in K562 and K562AR, but altered the membrane 
morphology in MCF-7TaxR after treatment. Our data, therefore, show no 
significant changes in the biophysical properties of drug sensitive or drug 
resistant cancer cells following modulator therapy, with the exception of MCF- 
7TaxR. There has been a disparity between DEP and flow cytometry results. 
DEP and flow cytometry in combination indicated that DIOC5 is a substrate for 
P-gp. Furthermore, DEP has provided a more informative and a rigorous 
approach in revealing that it is the cytoplasm that varies between MDR and drug 
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sensitive cells. The study has demonstrated the application of DEP as a novel 
approach to aid a better understanding of the MDR phenotype in cancer cells. 
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4. A rapid assay of apoptotic progress in a mixed 
population by dielectrophoresis (DEP) 
4.1. Introduction 
Apoptosis is a process that plays a critical role in the embryonic stage of 
development and tissue homeostasis. In humans dysfunction of this process has 
been linked to pathogenesis of cancer and other diseases (Thompson, 1995). 
The term was first described by Kerr et al (1972) in a landmark paper in which 
they described the morphological features of cell death during development and 
tissue homeostasis characterised by nuclear and cytoplasmic shrinkage. They 
termed this process 'apoptosis' (derived from the Greek word meaning 'falling 
off, as of autumn leaves from a tree). Before the term was coined, this mode of 
I cell death was referred to as 'shrinkage necrosis . 
Initially, it was generally accepted that all programmed cell deaths were of 
apoptotic morphology, whilst accidental, non-physiological passive cell death 
displayed features of what was called cell necrosis (from the Greek word for 
'dying') or defined by Majno and Joris (1995) as oncosis (from the Greek word 
onkos, meaning swelling). This classification of cell death has made crucial 
contribution into the research of programmed cell death and providing clear-cut 
morphological clues to study the mechanisms behind cell death. Recently, it has 
been suggested (Hughes and Mehmet, 2003) that necrotic cell death also occurs 
during normal cell physiology and development and necrotic-like cell death is 
also regulated by a cellular intrinsic death programme. 
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The morphological changes in apoptotic and necrotic cells have been described 
(Hughes and Mehmet, 2003), where in apoptotic cells the main changes occur in 
the nuclear compartment with initial marked condensation in the chromatin. This 
is accompanied by convolution in the nuclear and cellular outlines and nuclear 
fragmentation. Surface protuberances separate from the plasma membrane and 
then re-seal to form membrane-bound apoptotic bodies that may or may not 
contain nuclear fragments. Due to cell shrinkage, the cell also loses its normal 
cell contacts and some surface elements, such as microvilli and cell-cell 
junctions, well before cellular budding and fragmentation takes place. Nuclear 
and cytoplasmic fragmentation is restricted in cells with a high nucleo- 
cytoplasmic ratio, such as thymocytes. Significantly, these apoptotic bodies were 
not found to provoke inflammation, but are phagocytosed by adjacent healthy 
cells or by professional phagocytes (Hughes and Mehmet, 2003). 
In necrotic cell death, the most prominent feature is the early disruption of the 
plasma membrane and the spilling of the contents to the surrounding. Swelling of 
necrotic cells and disintegration of the cytoplasmic organelles are apparent 
microscopically. The mitochondria become swollen and often contain granular 
densities, while ribosomes detach from their associated membranes. The 
chromatin in the nucleus condenses and ill-defined patches occur close or 
occupy the entire area in the nuclear membrane in apoptotic cells. At late stages 
of cell necrosis the chromatin disappears, an event called karyolysis. As 
opposed to the swelling in necrotic cells, there is a marked shrinkage in the 
apoptotic cells due to the extrusion of ions and contraction of the cytoskeleton 
(Hughes and Mehmet, 2003). 
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if we consider in more detail the events in the cell that mediate apoptosis, we 
find that the mitochondrion plays an important role. In the mid-1 990s, 
speciallised caspases were discovered and were found to be responsible for 
apoptotic morphology, drawing increased interest towards the cytoplasmic 
events seen towards the later stages of apoptosis. 
The mitochondrion has now become the centre of death control, as it controls the 
release of multiple death-triggering proteins that lead to the execution phase of 
apoptosis (as reviewed in Green and Reed, 1998). Among these proteins is 
cytochrome c, but there are also other important proteins, summarised in Figure 
4.1. The mitochondrion also contains pro-caspases which are released into the 
cytosol during apoptosis (such as pro-caspases-3, -2 and -9), as suggested by 
Hughes and Mehmet (2003). In addition to the liberation of pro-apoptotic factors 
and activation of the caspase cascade, a typical early characteristic of apoptosis 
is mitochondrial membrane permeabilisation followed by dissipation of the 
mitochondrial transmembrane potential (AWm). This potential is due to the 
asymmetric distribution of protons and other ions on either side of the inner 
mitochondrial membrane, which gives rise to a chemical (pH) and an electrical 
gradient, both of which are essential for the function of the mitochondria, for 
example in ATP synthesis. Disruption of Aym has been detected in cells 
undergoing apoptosis, indicating pemeability transition pore (PT) opening. 
However, the exact relationship (such as cause or consequence) between Aym 
and release of apoptotic factors is still a matter of debate. 
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Figure 4.11: A schematic of the factors involved in the apoptotic cascade, the external triggers can 
include heat shock, infection or drug treatment such as staurosporine. Procaspases Gan include 
8,9 and 10. 
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Lysosomal clestabilisation also plays an important role in apoptosis. The 
destabilisation can be initiated by a number of factors, such as oxidative stress 
(Brunk and Svenssson, 1999). Interestingly, lysosomal proteases (such as 
cathepsin D) release was found to precede the release of cytochrome c and the 
loss of Aym (Roberg et al, 1999). 
In other forms of apoptosis induction, such as that of cytokine withdrawal 
includes apoptosis, Khaled et al (2001 a) found that early stress-related events 
preceded cell death. Intracellular rise in pH (alkalinisation) took place peaking 
above pH 7.8 2-3 hour post interleukin-3 withdrawal, and induced a transient 
increase in the Aym. The authors noticed a sharp decline of ATP during this 
early period, and suggested that the rise in the intracellular pH inhibit the 
mitochondrial import of ADP, which consequently limits the ATP synthesis. The 
inhibition of the ADP import into the mitochondria, in turn reverses the 
FoFIATPase, which in turn consumes the ATP and pumps out protons, raising 
Aym. Proton outward pumping and the inactivity of the FoFIATPase, in a cytokine 
withdrawal induced apoptosis, was reported earlier (Khaled et al, 1999). In a 
similar method of apoptosis induction, intracellular alkalinisation was observed 
and was suggested to be mediated by pH regulator Na+/H+ exchanger (NHE1) 
(Khaled et al, 2001 b). Another study (Kim et al, 2003) suggested the rise in 
cytosolic pH to be mediated by the C17HC03- anion exchanger, where Cl- ions 
are moving out in exchange for HC03- ions moving in. 
The ionic influx/efflux plays an important role in apoptosis and some ions 
mediate the change in cell volume. The principle ion in question is K*, where its 
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intracellular concentration has been widely reported to be diminished during the 
apoptotic process. K+ is pumped out of the cell and cell shrinkage takes place, 
and the role of this ion is pivotal in the cell death programme (Bortner et al, 1997; 
Yu et al, 1997; Yu et al, 1999). Also, a transient increase in intracellular Na' has 
been reported prior to the loss of cell volume (Bortner and Cidlowski, 2003). An 
increased generation of reactive oxygen species has been reported (Li et al, 
1999), which leads to the transient increase in AWm. At later stages of apoptosis, 
the Aym was found to decrease as the mitochondria depolarises. In these late 
stages, massive Ca 2+ influx takes place (Dallaporta et al, 1998), as well as 
mitochondrial swelling prior to cell lysis (Wyllie et al, 1980). Furthermore, 
alterations in Ca 2+ signalling can affect the survival and functioning of cells 
reviewed by Kass and Orrenius (1999). Table 4.1 summarises the sequence of 
events associated with apoptosis described above, based on the information 
cited in the literature. 
In this chapter, we examine the use of DEP to shed light on these findings by 
looking at the changes in the dielectric properties over a period of 48 hours 
following induction of apoptosis in K562 cells using staurosporine. A study by 
Wang et al (2002) demonstrated the use of DEP in detecting changes in 
membrane dielectric properties of cultured human promyelocytic leukaemia (HL- 
60) during the early stages of apoptosis after treatment with genistein. We 
extended this by examining changes in both the cytplasm and membrane over 
longer incubation periods with staurosporine, and demonstrate that a broader 
range of effects can be observed. 
4.6 
Event Reference 
1) Alkalinisation, as pH T, ADP import is inhibited, Khaled et al, 1999 and 
limited ATP synthesis in mitochondria, inactivation 2001a 
of FoFIATPase and protons are pumped out. 
The T in pH was mediated by the activation of Khaled et al, 2001 b 
NHE1. 
The T in pH also mediated by the CI-/HC03- anion Kim et al, 2003 
exchanger (CI- out) and (HC03- in). 
A transient increase in Na+ Bortner and Cidlowski, 
2003 
Membrane capacitance declines Wang et al, 2002 
2) T K+ efflux, cell shrinks, phosphatidyl serine Bortner et al, 1997; Yu 
residues exposed et al, 1997; Dallaporta, 
1998; Yu et al, 1999 
3) T reactive oxygen species Li et al, 1999 
4) At later stagesi Aym depolarises Dallaporta, 1998 
5) Massive Ca 2+ influx, mitochondrial swelling prior Wyllie et al, 1980 
to cell lysis Dallaporta, 1998 
Table 4.1: Summary of the sequence of events associated with apoptosis from the literature 
4.2. Materials and methods 
4.2.1. Chemicals and reagents 
Staurosporine (Alexis Corporation, Nottingham, UK) was dissolved in dimethyl 
sulfoxide (DIVISO), and stored frozen as a1 mM stock solution and thawed prior 
to use. The other chemicals used in this chapter were provided as part of 
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commercially produced kits and their sources mentioned in the text. 
4.2.2. Cell culture and the induction of apoptosis 
Human chronic myelogenous leukaemia (K562) cells were cultured under the 
same conditions mentioned in Chapter 3. Briefly, cells were grown in 20mM 
HEPES modified RPMI-1640 medium supplemented with 10% heat-inactivated 
foetal calf serum (FCS), (Invitrogen, Paisley, UK), 2mM L- glutamine and 
100units/ mL penici Ili n-streptomycin, and passaged in non-vented flasks in a 
standard tissue culture incubator 371C. All cell culture reagents were obtained 
from Sigma Aldrich (Poole, UK). 
The cells were treated with an apoptosis inducing agent (staurosporine) (from 
Sigma Aldrich, Poole, UK) at 1 ýM or 2 ýM concentration depending on the 
density of cells and incubation period used. The incubation period included five 
time points (4,8,12,24 and 48 hours). For the earlier incubation time points (4 
and 8 hours), a density of 6x 105/ mL at 1 gM staurosporine was used. For the 
later time points (12,24 and 48 hours), a density of 3x 105/ mL at 2 ptM was used. 
This procedure was adopted in order to account for cell growth encountered in 
cultures at the longer time points and to have enough pharmacological exposure 
to staurosporine. 
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4.2.3 DEP experiments 
K562 cells were centrifuged at room temperature at 190 xg for 5 minutes. The 
pellet was washed and resuspended in isotonic medium consisting of 8.5% (w/v) 
sucrose plus 0.3% (w/v) dextrose buffer (Gascoyne et al. 1997), as described in 
the previous chapter. The final conductivity of the medium was adjusted to 2.5 
mS/m using PBS and the final conductivity, before use, was verified with a 
conductivity meter (IRS components Ltd, London, UK). The final cell population, 
depending on the incubation time point used, was counted using a 
haemocytometer and adjusted to approximately 3x1 05 cells/ ml (±15%) for DEP 
measurements. As before, a range of different frequencies (10 kHz-20 MHz) 
was used. The experiments were repeated many times (generally 4-6) with 
different populations, which were summed prior to modelling. The same set up 
and electrode arrangement were used as that in Chapter 3. 
4.2.4. Flow cytometry 
A Coulter Epics XL flow cytometer was used to measure fluorescence emitted by 
individually labelled cells using the following techniques: 
4.2.4.1. Annexin V assay 
In normal viable cells, the phosphatidylserine (PS) molecules are located on the 
cytoplasmic surface of the cell membrane. When apoptosis is induced, rapid 
alterations in the organisation of the phospholipids can occur leading to the 
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exposure of PS on the cell surface (Fadok et al, 1992; Martin et al, 1995). For 
these experiments, the rapid Annexin V-FITC detection kit (Oncogene, Boston, 
USA) was used. The assay principle uses a fluorescently labelled probe, a 
fluorescein isothiocyante (FITC) conjugate of Annexin V, to detect restructuring 
of the plasma membrane and apoptosis by flow cytometry. Necrosis is 
characterised by membrane pemeabilisation, necrotic cells bind to Annexin V- 
FITC. Propidium iodide (PI) was used to distinguish viable, early apoptotic cells 
and necrotic or late apoptotic cells. Viable cells do not bind to Annexin V-FITC or 
Pl. Early apoptotic cells have exposed PS but will still have intact membranes, 
and will bind Annexin V-FITC but exclude Pl. Necrotic or apoptotic cells in the 
late terminal stages will bind both Annexin V-FITC and Pl, as the PS groups will 
be exposed and externalised. 
Using the instructions provided in the 'Rapid Annexin V binding' assay kit, briefly, 
a population of around 0.5A 06 cells in culture media was mixed with 10 ýtl- of 
media binding reagent followed by 1.25 [tL Annexin V-FITC. The mixture was 
incubated for 15 minutes at room temperature in the dark. The suspension was 
then centrifuged at 1000 xg for 5 minutes and the supernatant was removed. 
The cells were then resuspended in 1x binding buffer. 10 ýtl- of PI was added to 
the suspension, and the samples were then placed away from the light and on 
ice ready for immediate analysis using flow cytometry. 
The analysis was performed using a flow cytometer emitting an excitation light at 
488 nm from laser. The detection was made using FL1 (FITC detector) at 518 
nm and FL2 at 620 nm for PI detection. Adjustments were made to minimise 
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overlap between these two measurements. The log of the fluorescence made by 
Annexin V-FITC was displayed on the x-axis and the 109 of PI fluorescence was 
on the Y-axis. The evaluation of the results was based on the visualisation of a 
cytogram. As shown in Figure 4.2, the cytogram consisted of a set of 4 squares 
(quadrants), the square in the bottom left hand corner corresponded to viable 
cells, bottom right hand corner was that of cells in the early apoptotic stage and 
the top right hand corner was that of late apoptotic or necrotic cells. In the corner 
of each quadrant, a percentage number was displayed conferring to the 
percentage of cells in that category. 
(L) 
c) 
GO2 
Z 
Late 
apoptotic 2 
/necrosis 
4 
Early 
Viable apoptosis 
FITC Log fluorescence 
Figure 4.2: A representation of a cytogram in the evaluation of annexin V results by flow 
cytometry 
4.2.4.2. TMRE (tetramethylrhodamine ethylester) assay 
TIVIRE (purchased from Molecular Probes, Leiden, The Netherlands) is a highly 
fluorescent permeant cationic and a lipophilic dye. It is used as a fluorescent 
4.11 
probe to monitor the membrane potential of mitochondria, as it accumulates in 
the negatively charged mitochondrial matrix according to the Nernst equation 
potential (Ehrenberg et al, 1988). TIVIRE stock was prepared at a concentration 
of 1 mM made with DMSO and stored at -200C and thawed prior to use. The 
cultured K562 cells, at a density of approximately 2.5 x 105/ mL were grown 
overnight, under the usual cell culture conditions (as described in Chapter 3) and 
then treated with 1 ýM staurosporine on the following day. Cells were exposed to 
the drug for a number of hours using the time points (4,8,12,24 and 48 hours). 
A working stock solution of 1 OýM of TIVIRE was made. After each time point, the 
cells were centrifuged at 200 xg for 3 minutes and the pellet was resuspended in 
a medium containing PBS supplemented with 2 g/L D-glucose. This was done in 
order to reproduce the usual conditions cells normally grow in. The cells were 
then incubated with TIVIRE (at a final 1 OOnM concentration) for 40 minutes away 
from light, and again under the normal cell culture conditions. The cells were 
centrifuged at x 190g for 3 minutes, after which the pellet was resuspended in 
500 4L of the PBS medium (with 2 g/L D-glucose). A positive control TIVIRE 
sample was also prepared, which involved following the same procedure 
described earlier, except that an uncoupler carbonyl cyanide m- 
chloropheny1hydrazone (CCCP) was added at 10 ýW final concentration before 
adding TIVIRE (1 OOnM final concentration) to the cells, and the cells were then 
incubated for 3 minutes at room temperature. All samples were then analysed 
using a flow cytometer using fluorescence at 548nm. CCCP is a protonophore, 
which depolarises the mitochondria by abolishing the proton gradient across the 
inner mitochondrial membrane (Martin et al, 1991; Gartner et al, 1995). Different 
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samples were set up and analysed, these were: control non- TMRE- treated 
K562 cells, cells that have been treated with staurosporine at different incubation 
times and a positive TIVIRE control sample. 
In order to assess the mitochondrial membrane potential (A Tm) of cells, the shift 
of the FL3 peak was compared to control (K562 untreated) and to that of positive 
control TIVIRE cells. The peak shift gives an indication of the extent of membrane 
hyperpolarisation or depolarisation (shifting the peak to the right and left, 
respectively). 
4.3. Results 
4.3.1. DEP experiments 
Table 4.2 summarises the biophysical properties of K562 before and after 
treatment with staurosporine. The table shows the different time points of 
incubation with staurosporine, after which DEP data were collected. The results 
show insignificant changes in the cytoplasmic permittivity, as using any value 
between 40-80 gave the same best fit curve. 
After treatment with staurosporine, more significant changes were seen in the 
cytoplasmic conductivity at different time points. After 4 hours of treatment, the 
cells were showing signs of mitochondrial membrane hyperpolarisation, as the 
cytoplasmic conductivity increased from 0.23 to 0.40 Slm before and after 
treatment, respectively (Figures 4.3 and 4.4). Hence, the data were suggestive of 
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an increase in the ionic concentration of the cytoplasm after 4 hours of 
incubation with staurosporine. The hyperpolarisation pattern appeared to 
continue at this elevated level, with values remaining as high as 0.45 and 0.42 
S/m after 8 and 12 hours of incubation, respectively. Table 4.2 also shows that 
the specific membrane capacitance (Crpe,, ), which provides an indication of the 
membrane morphology state, varied between these time points. After 4 hours of 
treatment with staurosporine, Crpe,,, was increased from 3.9 to 4.1 mF/M2 . K562 
cells then demonstrated an elevated Cspec at 7.4 mF/M2 after 8 hours of 
incubation (Figure 4.5). This parameter remained at this level for the remainder 
of this study (Figure 4.6). The increase in Cspec indicates an increase in the 
membrane morphology which could be the result of more blebbing taking place 
in the membrane of these cells. Cspec is calculated by taking surface area into 
account, hence blebbing increases the surface area, which may account for the 
increase in Csp,,, seen after 8 hours of staurosporine treatment. 
After 24 hours of incubation with stauropsporine, the DEP results (Figure 4.7) 
highlighted the possibility of more than one population accounting for the 
different dielectric properties obtained. As shown in Table 4.2, each population 
exhibited different cyoplasmic concluctivity. Values started from 0.5 S/m, for 
population 1, indicating that these cells possessed a high ionic strength. 
Population 2 demonstrated a reduced cytoplasmic conductivity of 0.03 S/m, 
which might indicate cells later in their life cycle, or apoptosis, whilst population 3 
showed a cytoplasmic conductivity of 0.003 S/m, indicating that the cells have 
probably gone into the necrotic stage. 
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DEP d ata 
Cytoplasm Membrane 
CY (S/M) 6 Ks (S) Cspec (mF 7m) 
0.009 
Incubation conditions of K562 cells 40- (0.008- 
before treatment with staurosporine 0.230 (0.220-0.240) 80 0.010) 3.9 (3.3-3.6) 
Hours of incubation with 
staurosporine 
0.008 
40- (0.007- 
4 0.400 (0.30-0.50) 80 0.009) 4.1 (3.8-4.2) 
0.09 
40- (0.007- 
8 0.450 (0.44-0.46) 80 0.010) 7.4 (6.9-7.8) 
0.006 
40- (0.005- 
12 0.420 (0.41-. 43) 80 0.007) 7.5 (7.2-8.2) 
24 
40- 
Population 1 0.500 (0.400-0.600) 80 0.01 7.0 (6.9-7.1) 
40- 
Population 2 0.030 (0.02-0.040) 80 0.01 7.0 (6.9-7.1) 
40- 
Population 3 0.003 (0.002-0.004) 80 0.01 7.0 (6.9-7.1) 
48 
40- 
Population 1 0.003 (0.002-0.004) 80 0.01 6.9 (6.8-7.0) 
40- 
Population 2 0.150 (0.140-0.160) 80 0.01 7.6 (7.5-7.7) 
Table 4.2: DEP results summarising the dielectric parameters measured after different incubation 
periods with staurosporine 
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The parameters in Table 4.2 were obtained using the radius measurements in 
Table 4.3 below: 
After incubation (hours) 
4 
8 
12 
24 
8.0 
7.6 
7.6 
6.7 
48 6.8 
Table 4.3: K562 cell radius measurements used for modelling and obtaining the parameters in 
Table 4.2 at different incubation periods with staurosporine 
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Figure 4.5: DEP collection spectra of K62 cells following 8 hours treatment with staurosporine 
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Figure 4.6: DEP collection spectra following 12 hours treatment with staurosporine 
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Figure 4.7: DEP collection spectra following 24 hours of treatment showing the presence of more 
than one population 
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After 48 hours of exposure to staurosporine, the DEP results (Figure 4.8) have 
again demonstrated that more than one cell population could be present. 
Population 1 could represent the dead or necrotic cells, as the cytoplasmic 
conductivity was 0.003 S/m. Population 2, on the other hand, exhibited a 
cytoplasmic conductivity of 0.15 S/m, indicating a higher ionic content relative to 
population 1. The results shown in these figures, and the parameters calculated 
from the data, have been the average of at least 6 experiments. 
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Figure 4.8. DEP collection spectra following 48 hours treatment with staurosporine showing the 
presence of two populations 
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4.3.2. Flow cytometry 
4.3.2.1. Annexin V results 
Figure 4.9 shows the annexin V data for K562 at different incubation periods with 
staurosporine. The control untreated cells showed a reasonable number of viable 
cells with a dense population in the viable quadrant. This was demonstrated by 
the percentage in the bottom left hand quadrant, that being 84%, with very low 
and insignificant numbers in the other quadrants (12% and 4%, for early and late 
apoptotictnecrotic populations, respectively). 
After 4 hours of treatment, cytogram (B) showed a slight increase in the number 
of cells within the early apoptotic quadrant relative to the control untreated cells 
(A). The percentages were 35% in the early apoptotic quadrant after 4 hours of 
treatment relative to 12% of the control untreated cells. 
After 24 hours of treatment (Figure 4.9 C), the assay seemed to reveal the 
presence of 3 populations highlighted by the 'clouds' of varying intensity. The 
percentages were suggestive of a significant number of cells being in the 
late/apoptotic stage (44%) relative to the early apoptotic stage (quadrant B, 
11 %). At this time point, approximately 50% of the population seemed to be 
viable (56%). 
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Figure 4.9: Annexin V cytograms showing the stages of apoptosis at different incubation periods 
with staurosporine: control (A), 4 hours (B), 24 hours (C) and 48 hours (D). Experimental controls 
on untreated K562 with Pl only (E) and FITC only (F). 
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After 48 hours of treatment (Figure 4.9 D), the cytogram gave a slightly clearer 
indication to the presence of more than one population and showed that the 
majority of the cells were in the late apoptotictnecrotic stage, with 59% of the 
population present in that quadrant, compared to 6% in the early apoptotic 
quadrant and 35% in the viable quadrant. 
Control untreated cells were used in the experiment, shown in Figure 4.9 E and 
F. Control untreated cells were incubated with PI alone (cytogram E) and FITC 
alone (cytogram F). Untreated cells are expected to have a high number of 
viable cells with a low number in the early apoptotic stage. Viable cells do not 
bind PI or FITC, reflected in the lower left hand quadrant in the cytogram. 
Cytograms E and IF demonstrated that the majority of the control untreated cells 
were viable with percentages of 82% and 89% for PI and FITC Jespectively. 
The experiments were repeated at least 3 times, the results of all of which have 
not been included, as they all provided the same pattern, a representation of 
these is in Figure 4.9. 
4.3.2.2. TMRE 
Figure 4.10 shows the mitochondrial membrane potential (ATm) changed at 
different incubation periods with staurosporine. The first plot (A) showed K562 
controls untreated cells without the TIVIRE, which showed no significant 
fluorescence emitted. After using TIVIRE (B), the cells exhibited a shift in the 
peak indicating that they have taken up TMRE and fluorescence was emitted. As 
a different control, the cells were incubated with the uncoupler (protonophore), 
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which depolarised the mitochondria by abolishing the proton gradient across the 
inner mitochondrial membrane, producing a peak that shifted to the left relative 
to CCCP untreated cells. Figure 4.10 C has evidently shown the effect of using 
CCCP, as the peak has shifted to the left indicating a reduction in ATm 
(depolarisation) relative to the CCCP untreated cells (B). Incubating the cells with 
staurosporine has demonstrated changes in the AlFm, after 4 hours of exposure 
to staurosporine (D), the peak shifted slightly to the right in comparison with the 
TIVIRE only treated cells (B), showing a slight increase in ATm that corresponds 
to a slight hyperpolarisation state. This state appears to have continued after 8 
hours of exposure (E). However, a small sub-population was apparent at this 
time point that exhibited a depolarisation state (i. e. it is displaced to the left). 
After 24 hours of exposure (F), the results indicate the presence of more than 
one population, one of which produced a peak shift to the right 
(hyperpolarisation) and the other had a peak that shifted to the left 
(depolarisation) relative to (B). 
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Figure 4.10: Flow cytometric plots showing changes in the mitochondrial membrane 
potentials. K562 control cells without TIVIRE (A), control K562 with TIVIRE but without 
staurosporine (B), K562 with no staurosporine but with the unGoupler CCP (C), K562 with 
TIVIRE following staurosporine exposure: 4 hours (D), 8 hours (E) and 24 hours (F). 
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4.4. Discussion 
4.4.1. Early apoptosis 
The DEP results highlighted an increased ionic concentration in the cytoplasm 
following 4 hours of incubation with staurosporine relative to untreated cells. This 
was indicated by the rise in conductivity from 0.23 S/m to 0.4 S/m, respectively 
(Table 4.2). The rise in the cytoplasmic conductivity was persistent after 12 hours 
of incubation with 1 ýN staurosporine. Furthermore, the TMRE assay 
demonstrated a slight mitochondrial membrane (MMP) hyperpolarisation for up 
to 8 hours of treatment. This was evident in the peak shifting to the right hand 
side relative to the TIVIRE untreated cells (Figure 4.10 B and D). The annexin V 
assay showed that early apoptosis was evident after 4 hours of treatment relative 
to control untreated cells (Figures 4.9 B and 4.9 A, respectively). 
The annexin V and TIVIRE results collectively have indicated that at early stages 
of apoptosis, mitochondrial hyperpolarisation took place. Furthermore, DEP 
revealed a persistent increase in the cytoplasmic conductivity for up to 12 hours 
of treatment with staurosporine. This early mitochondrial hyperpolarisation 
pattern in apoptosis was reported in several previous studies (Green and Reed, 
1998; Marzo et al, 1998; Li et al, 1999). A recent study (Kim et al, 2003) showed 
that Lactacystin-induced apoptosis in rat retinal pigment epithelial cell line (RPE)- 
J, is closely associated with an early mitochondrial hyperpolarization induced by 
intracellular alkalinisation. The increase in the cytoplasmic conductivity may 
possibly be caused by one or more mechanism. One such mechanism may 
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involve the increased generation of reactive oxygen species (ROS), a 
phenomenon reported in a study by Li et al (1999). In their report, they showed 
that p53-induced apoptosis caused an increase in ROS leading to a transient 
increase in the MMP. Other studies (Khaled et al, 1999,2001 a, 2001b; Belaud- 
Rotueau et al, 2000) have described the involvement of an increased 
intracellular pH in mitochondrial hyperpolarisation as a consequence of cytokine 
withdrawal induced apoptosis. A more recent study (Kim et al, 2003) aimed to 
investigate whether mitochondrial hyperpolarisation, in a different apoptosis- 
induced model, was evoked by cytosolic alkalinisation. The authors found that 
early mitochondrial hyperpolarisation indeed a consequence of intracellular 
alkalinisation which was mediated by CIIHCO-3anion exchanger. Those findings 
supported the idea that the intracellular alkalinisation preceded and induced 
mitochondrial hyperpolarisation. The idea that the rise in intracellular pH induces 
mitochondrial hyperpolarisation was similar to the finding by Khaled et al (2001 a) 
using a model of cytokine withdrawal-induced apoptosis. 
Another possible mechanism may counterintuitively involve ionic efflux. Although 
the early events triggering apoptosis are still poorly understood (Porcelli et al. 
2003), a number of studies reported a dramatic decrease in the intracellular ions 
during apoptosis, primarily K' and Na' (McCarthy and Cotter, 1997). The loss of 
K+ was up to 95% (Hughes et al, 1997), the intracellular K+ was reduced from 
150 to 50 mM in a fibroblast cell line (Barbiero et al, 1995) and K+ concentration 
was found to be as low as 35 mM in shrunken apoptotic thymocytes (Hughes Jr 
and Cidlowski, 1999). In support of a low K+ concentration was the study by 
Montague et al (1999), where shrunken cells, of lymphocytes treated with 
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glucocorticoid, were shown to be K+ depleted. 
A decrease in Na+ has also been reported in apoptotic lymphoma cells (Bortner 
et al, 1997) and in Jurkat cells (Gomez-Angelats et al, 2000). The loss of Cl- 
content has been associated with cell volume decrease (Yu and Choi, 2000; 
Okada and Maeno, 2001. The efflux of K+ accompanied by the efflux of Cl- 
permits the osmotic movement of water out of the cell, generating a 
characteristic loss of cell volume (apoptotic volume decrease, AVID) (Porcelli et 
al, 2003; Lang et al, 2000). In a staurosporine induced apoptosis study, the data 
by Porecili et al (2003) suggested that upregulation of Cl- and K+ channels might 
be a very early event required for the subsequent onset of AVID that results in 
apoptosis. Apoptotic cell shrinkage has also been associated with a decrease in 
the intracellular K+ and Na+ (McCarthy and Cotter, 1997). This loss of cytosolic 
K+ occurs before cell shrinkage, consistent with a role for K+ efflux in cell volume 
reduction, and K+ was also seen before the production of ROS (Dallaporta et al, 
1998). 
Concomitant with the loss of intracellular ions is a dramatic reduction in cell size 
characteristic of apoptosis. For example Maeno et al (2000) reported an 
approximately 30% loss in cell volume in HeLa and U937 cells 4 hours after 
treatment with staurosporine. This suggests another possible mechanism of 
increase in cytoplasmic conductivity, which relies on the loss of cell volume. The 
increase in the conductivity (which is proportional to ionic concentration, and 
hence inversely proportional to cytoplasmic volume) seen from the DEP data 
may be caused by the loss of the cell volume as a result of ionic efflux and water 
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loss causing the remaining ions to become more concentrated inside the cell. 
Although the 30% decrease in cell volume does not completely account for the 
near-doubling of the cytoplasmic conductivity seen in our data, this can be 
accounted for if approximately 40% of the cell is composed of material which 
does not contribute to volume loss (for example, the organelles and 
cytoskeleton). This is illustrated in the schematic below (Figure 4.11). 
Shrunken cell 
Cytoplasm 
Organelles etc. 
B 
Figure 4.11: During apoptosis, cells shrink by 30% of their normal volume; however the 
observed change in conductivity suggest that the volume has halved. If the cell consists only of 
cytoplasm (A), the 30% loss of volume does not correspond to a sufficiently great increase in 
conductivity. However, if we account for organelles and other cell bodies (B), indicated in the 
same loss Of Gell volume gives a MUGh more signifiGant cleGrease in the volume of the GytOplasm, 
and hence a more significant rise in conductivity. 
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Normal cell 
The proposed mechanism goes in agreement with an earlier study (Wyllie et al, 
1980 and reviewed in Trump and Berezesky, 1996). They reported that in 
apoptosis, cells shrink with densification of the cytosol, more extreme clumping 
of nuclear chromatin, formation of large cytoplasmic blebs and changes in 
mitochondria similar to initial condensation. 
Interestingly, the DEP results highlighted significant changes in the specific 
membrane capacitance, which increased following staurosporine treatment from 
around 4.1 to 7.4 mF/M2 (for 4 and 12 hours of incubation, respectively), 
indicating possible membrane morphology changes, such as the formation of 
apoptotic bodies. The capacitance remained high up to 12 hours of incubation. 
Generally, the surface conductance did not vary significantly during apoptosis. 
4.4.2. Late Apoptosis 
DEP results revealed that after 24 hours of incubation with staurosporine, more 
than one population was present; multiple populations were also seen after 48 
hours of incubation with staurosporine. The dielectric parameters extracted from 
these populations at the two time points are summarised in Table 4.2. After 24 
hours of treatment, DEP results (Figure 4.7) showed the presence of 3 
populations, believed to be dead or necrotic cells where the cytoplasmic 
conductivity was very low; a depolarized population with low cytoplasmic 
conductivity consisting of possibly late apoptotic cells, and a highly-conductive 
population that is still behaving as if in early apoptosis. The cytoplasmic 
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conductivities of these three populations were 0.003,0.03 and 0.50 S/m, 
respectively. 
Comparing DEP data with those obtained using Annexin V (Figure 4.9 C), three 
populations could also be observed with similar properties and with greater 
percentages lying in the quadrants corresponding to viable (56%) and late 
apoptotic or necrotic cells (44%). On the other hand, TIVIRE data showed the 
presence of a second population with depolarised MMP in addition to the 
hyperpolarised population (Figure 4.10 F). When the treatment was prolonged to 
48 hours, the DEP results revealed the presence of 2 populations, one 
corresponding to dead or necrotic cells and the second to a depolarised 
population with cytoplasmic conductivities of 0.003 and 0.150 S/m, respectively 
(Table 4.2). The quadrants from the Annexin V data showed a clearer 
representation of the cells distribution, with the majority lying in the late apoptotic 
or necrotic quadrant (59%) (Figure 4.9 D). 
The populations of cells seen at 24 hours treatment showed different dielectric 
properties, principally cytoplasmic conductivities, relative to that of the control 
untreated cells (0.23 Slm) (Table 4.2). Possible explanations for this include the 
continuous efflux of the K+ and Na+ while the cell volume was still shrinking. The 
remaining ions are, therefore, still relatively more concentrated, thus giving a 
hyperpolarised population I- Population 2 was strongly depolarised as it is 
possibly reaching the end of its apoptotic cycle and close to dying, so the ionic 
efflux is over-riding. Population 3 represented the dead necrotic cells, which had 
ruptured. 
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After 48 hours of treatment, one Population corresponded to (dead) necrotic cells 
as the cytoplasmic conductivity was very low and the second was weakly 
depolarised with a cytoplasmic conductivity of 0.15 S/m. This population might 
reflect the last stages of apoptosis where ionic influx has been reported. The 
intracellular a 2+ as been reported to increase and can result from the influx 
from the extracellular space, or from redistribution from intracellular stores shortly 
before lysis (Wyllie et al, 1980; Dallaporta et al, 1998). Also, Trump and 
Berezesky (1996) hypothesised the increase in intracellular calcium stimulate the 
K+ loss and shrinkage prior to cell death. Ca 2+ is known to be the key regulator of 
many enzymatic reactions in the cell. The mitochondrion alone has 3 Ca 2+ 
transport systems (a Ca 2+ uniport, Ca 2+/H+ antiport and Ca 2+/Na+ antiport) 
responsible for influx and efflux of Ca 2+. Mitochondria also have non-specific 
channels called permeability transition pores (PTP) which may also take part in 
Ca 2+ release. Mitochondria are usually present in close contact with endoplasmic 
reticulum (where Ca 2+ is stored) (reviewed in Skulachev, 1999). It might be 
possible that the cytoplasmic conductivity seen for the 0.15 S/m population at the 
end of the 48 hours incubation with staurosporine was due to the high Ca 2+ 
content coming from the mitochondria, as they swell prior to cell death (Trump 
and Berezesky, 1996). Another contributor might be the increased intracellular 
Na' as reviewed by Yu (2003). 
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As indicated in the previous section, the specific membrane capacitance (Crpec) 
of the two populations after 48 hours treatment retained an elevated value. 
These particular data might further reflect the membrane morphology and size 
changes seen in this population with regards to blebbing or folding (Trump and 
Berezesky, 1996). 
If we attempt to map the events described in this chapter with other known 
apoptotic events described in the literature, we can obtain an overall sequence of 
apoptotic processes similar to those shown in Table 4.4. As can be seen, the 
events indicate that the processes attributed to the DEP data are entirely within 
the realms of what is known about the progress of apoptosis, whilst also 
shedding new light on these key cellular events. 
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Corresponding 
findings (from DEP, 
Event annexin V& TMRE) 
after staurosporine 
treatment 
Alkalinisation, as pH T, ADP import is inhibited, (4-12-hours) 
limited ATP synthesis in mitochondria, inactivation 
of FoF, ATPase and protons are pumped out. Increased cytoplasmic 
The T in pH was mediated by the activation of conductivity (ionic 
NHE1. concentration) as the 
The T in pH also mediated by the Cl-/HC03- anion cell shrinks, ions 
exchanger (Cl- out) and (HC03- in). 
A transient increase in Na+ 
2) T K' efflux, cell shrinks, phosphatidyl serine 
residues exposed 
3) T reactive oxygen species 
4) At later stages, Aym depolarises 
5) Massive Ca 2+ influx, mitochondrial swelling prior 
to cell lysis 
become more 
concentrated 
(24-48 hours) 
Multiple populations 
occur as cells depolarise 
and die. The influx of 
Ca 2+ may be reflected by 
populations seen with 
intermediate cytoplasmic 
conductivity 
Table 4A A table summarising the results obtained collectively from DEP, annexin v and TIVIRE 
shown in parallel with the information in literature (as discussed in Table 4.1) 
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4.5. Conclusions 
DEP can be used as a rapid, non-invasive technique to detect early dielectric 
changes in apoptosis, where semi -quantitative results can be obtained. 
Furthermore, it can be used to differentiate between multi- populations on the 
basis of their dielectric properties and, therefore, gives an accurate assessment 
of key stages within apoptosis. 
The DEP results in this chapter indicate that K562 cells increase in cytoplasmic 
conductivity within the first 4 hours after exposure to staurosporine, which then 
lasts beyond 12 hours of exposure. The Annexin V assay indicated that this 
occurred synonymously with early-stage apoptosis. Furthermore, within this time 
period, TIVIRE data pointed to hyperpolarisation in the MMP. Although no work 
exists which directly explains the rise of cytoplasmic conductivity at this stage of 
apoptosis, a number of known events may explain this behaviour. The most 
likely cause of this effect is cell shrinkage due to water loss triggered by ion (K+, 
Cl-) efflux, resulting in an increase in the intracellular concentration of the 
remaining ions 
After 24 and 48 hours of incubation with staurosporine, multiple populations were 
detected by DEP, highlighting the dielectric changes that the cell undergoes 
before death or necrosis. The Annexin V results showed that the majority of cells 
were identified as being in the late stages of apoptosis and the TIVIRE data 
indicated both depolarised and hyperpolarised MMP in the population. The DEP 
results at these two time points showed cells with elevated, diminished and 
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depleted cytoplasmic conductivities after 24 hours of exposure to staurosporine, 
with the latter two populations only being observed after 48 hours of exposure. 
The reduction effect might be associated with the later stages of apoptosis. This 
may be due to cell swelling, causing the cell ionic content to become relatively 
more dilute and significantly lower in cytoplasmic conductivity relative to control 
untreated cells. However, this conductivity was significantly higher than the third 
population (assumed to be dead cells). This could be the result of an increased 
ionic content, such as an influx of Ca 2+ and Na+ through the membrane channels 
from the extracellular fluid, and additionally from the mitochondria in the case of 
Ca 2+ . 
These suggestions may need further and closer examination, by using potential 
blockers to eliminate for the changes seen, as well as perhaps using other 
apoptosis-inducing techniques to examine whether similar effects are observed. 
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5. Conclusion 
This work presents a study of the biophysical properties of cancer cells in a 
range of pharmacological scenarios, focusing on the effects of pharmacological 
agents both on drug-sensitive and multidrug resistant leukaernic and breast 
cancer cell lines. In this work, dielectrophoresis has been used as a non-invasive 
technique to examine dielectric properties of drug resistant and sensitive cancer 
cells before and after treatment with anti cancer drugs, and with a 
chemosensitiser. The results of this work have provided a better understanding 
of the physiology of different types of cancer cells, and allowed direct 
comparisons of these properties for both the membrane and the cytoplasm. 
Dielectrophoresis (DEP) is the motion of particles, (in this case cells), in non- 
uniform electric field gradients. The non-uniform nature of the field generates 
Coulombic forces of differing magnitudes at either pole of the cell dipole, 
resulting a net force and a resultant motion. The gradient of the electric field and 
the polarisibility of the cell dictate the motion of the cell. The polarisiblity is a 
function related to the dielectric properties of both the cell and the medium 
surrounding it. If the cell is more polarisable than the medium, the net motion 
acts in the direction of highest electric field regions; a phenomenon called 
positive dielectrophoresis, where cells are attracted to the electrodes. If the 
medium is more polarisable than the cell, net motion acts towards low-field 
regions; a phenomenon called negative dielectrophoresis, as cells are repelled 
from the electrodes. These properties are dependent on frequency of the applied 
electric field. 
5.1 
Cancer is one of the biggest causes of death, and common methods of treatment 
include radiation, local excision and chemotherapy. A significant impediment in 
the chernotheraputic treatment of cancer is the acquisition of the ability of cancer 
cells to prevent the drug from reaching its target (typically in the nucleus), 
thereby rendering the cell resistant to the effects of the drug. The term "multi- 
drug resistant" (MDR) is used to characterise those cells that have acquired 
cross-resistance to many anti-cancer drugs having no common structure, but are 
generally natural product in origin. A number of mechanisms have been 
suggested by which cells acquire MDR. One of which is the overexpression of 
membrane glycoproteins, collectively termed as the ABC (ATP-binding-cassefte) 
transporters. A typical example of the ABC transporters is the membrane P- 
glycoprotein pump (P-gp), which effluxes anti cancer drugs outside the cells, 
thereby reducing the intracellular accumulation of the drugs and reducing their 
cytotoxic effects as a result. Another form of MDR is that involving reduced anti 
cancer drug cytotoxicity, as the drug is sequestered into vesicles, as part of the 
intricate intracellular trafficking system. 
In order to assess the biophysical properties of MDR cells, previous studies have 
used a membrane potential sensitive dye (DIOC5) and flow cytometry to 
compare membrane potentials of drug sensitive and resistant cancer cells before 
and after treatment with a chemosensitiser (agents that are designed to reverse 
drug resistance). Previously, it was found that the membrane potential was 
decreased significantly after treating the resistant cell lines with the 
chemosensitiser. Our DEP data, however, showed no significant changes in the 
biophysical properties of drug sensitive or drug resistant cancer cells following 
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mod ulator/chemosensitiser therapy. The disparity between DEP and flow 
cytometry results indicated that DIOC5 acts as a substrate for P-gp. 
Furthermore, the results probed biophysical differences between cell lines, with 
multidrug resistant (MDR) cells exhibiting a higher cytoplasmic conductivity than 
the parental cells. These findings are suggestive of a difference in the relative 
ionic strengths of the turnour cells. The technique has also revealed differences 
in the membrane morphology of MCF-7 relative to MCF-7TaxR, whilst showing 
an absence of such membrane differences in K562 relative to K562AR. XR9576, 
a P-gp specific chemosensitiser/modulator did not exert any effects on the 
cytoplasm or membrane parameters in K562 and K562AR but altered the 
membrane morphology in MCF-7TaxR after treatment. DEP has therefore 
provided a more informative and a rigorous approach in revealing that it is the 
cytoplasm that varies between MDR and drug sensitive cells. Moreover, using 
the DIOC5 method of probing membrane potential provides artefactual results, 
as the dye is a substrate for ABC transporters. 
Further studies were then performed to investigate differences between sensitive 
and drug resistant cell lines. Reports have suggested that MDR can be mediated 
by the overexpression of an ABC-transporter, which includes P-gp, or by drug 
sequestration. DEP was used to reveal and compare dielectric properties of 
ABC- and non- ABC- based modes of MDR. Different cell lines were compared, 
namely MDR chronic myelogenous leukaemia (K562AR) and breast cancer 
(MCF-7TaxR and MCF-7DoxR), relative to their parent drug sensitive cell lines. 
The results pointed to significant differences in the cytoplasmic ionic content with 
no significant differences in the membrane parameters. The results also 
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suggested that two mechanisms of drug resistance were present. One of these is 
P-gp- dependent and relies on the pump acting as a Cl- channel, as in K562AR. 
The other mechanism is non- P-gp -dependent, as in MCF-7DoxR, where the 
principal mechanism of drug resistance is believed to be that of drug 
sequestration and vesicular trafficking, as the cytoplasmic conductivity was 
higher than the parent. This MDR cell line lacked the expression of P-gp, and the 
potential mechanism of this might involve a defect in the Na+/H+ ATPase (NHE), 
resulting in the accumulation of Na+ in the cytoplasm. In MCF-7TaxR, however, a 
low cytoplasmic conductivity was detected relative to the parent, despite its 
overexpression of P-gp. We believe that P-gp is behaving more like a regulator 
in the MCF-7TaxR, implying a deactivating role in the Cl- channels, hence 
possibly resulting in a reduction of the total ionic content, giving a lower 
cytoplasmic conductivity relative to the parent. 
Another aspect of the interaction between cancer cells and pharmacological 
agents is the induction of apoptosis (programmed cell death). This was the third 
focus point of this research. A recent study reported the use of DEP to detect 
early stages of apoptosis and found a significant decrease in the specific 
membrane capacitance after 4 hours of apoptosis induction. DEP was used to 
study apoptosis by examining the cytoplasm as well as the membrane 
parameters at early, and extending the study to look at later stages of apoptosis. 
Other well established flow cytometry based techniques, namely annexin V were 
used to characterise the stage of apoptosis, and the mitochondrial membrane 
potential was investigated and compared by using the TIVIRE assay. DEP results 
indicated that K562 cells had an increased cytoplasmic conductivity within the 
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first 4 hours after exposure to staurosporine, which then lasted beyond 12 hours 
of exposure. The Annexin V assay indicated that this occurred simultaneously 
with early-stage apoptosis. Furthermore, within this time period, TIVIRE data 
pointed to hyperpolarisation in the MMP. Although no work exists which directly 
explains the rise of cytoplasmic conductivity at this stage of apoptosis, a likely 
cause of this effect that can be suggested is that of cell shrinkage due to water 
loss trigger by ion (K', Cl-) efflux, causing concentration of the remaining ions. 
Interestingly, after 24 and 48 hours of incubation with staurosporine, multiple 
populations were detected by DEP, highlighting the eventual dielectric changes 
that the cell undergoes before death or necrosis. The Annexin V results showed 
that the majority of cells were identified as being in the late stages of apoptosis 
and the TMRE data indicated both depolarised and hyperpolarised MMP in the 
population. The DEP results at these two time points showed cells with elevated, 
diminished or effectively lost cytoplasmic conductivities after 24 hours of 
exposure to staurosporine, with only the latter two populations being observed 
after 48 hours of exposure. The reduction effect might be associated with the 
later stages of apoptosis. This may be due to cell swelling, causing the cell ionic 
content was becoming more dilute and the significantly lower cytoplasmic 
conductivity obtained relative to control untreated cells. However, this 
conductivity was significantly higher than the third population (assumed to be 
dead cells). This could be the result of an increased ionic content, such as an 
influx of Ca 2+ and Na+ through the membrane channels from the extracellular 
fluid, and additionally from the mitochondria in the case of Ca 
2+ 
. 
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Further work will be required in order to further explore some of these 
hypotheses produced from the results obtained. Firstly, activities of certain ionic 
channels should be investigated to address the changes in the cytoplasmic 
conductivity of the ABC- and non- ABC mediated MDR. This could be performed 
by the use of channel blockers, and investigating overexpression of these 
channels to eliminate for the changes seen. Examples may include Ba 2+ and 
quinine for K+- channel, 5-nitro 2-(3-phenylpropylamine) benzoic acid (NPPB) for 
Cl- channel blockers and 4-acetoamido-4'-isothiocyanostilbene-2,2'-disulfonic 
acid (SITS) for Cl-/HC03- channel blockers. This work could also be extended by 
investigating the cytoplasmic pH using the fluorescent pH indicator SNARF 1, 
and the cytoplasmic ionic composition using techniques such as time-of-flight 
secondary ion mass spectrometry (TOF-SIMS). The work on apoptosis can be 
extended by increasing the time resolution by including additional staurosporine 
incubation periods, and test other modes of apoptosis induction, such as UV 
radiation or clexamethasone on the cell lines used. 
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